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ABSTRACT   
 
The researcher has noticed certain unhealthy trends in the choices of contraceptive methods 
by PLIHIV women in Cofimvaba. It is a significant concern that there appear to be a disjoint 
between the knowledge imparted on the women on healthy contraceptive choices and their 
practical choice of contraceptive methods. The researcher wants to identify the factors 
influencing the choice of contraceptive methods by PLHIV women in this area. The research 
data were collected with a questionnaire and descriptive quantitative analysis was done on 
data collected on the knowledge, attitude, perception and practice of the women regarding 
HIV and contraceptive methods.  
 
The findings were that despite the high awareness (92%) amongst the PLHIV women about 
dual protection as the method of choice for them, only 4% are practising dual protection. The 
research also revealed that 40% of the women are still having unprotected sex. Only 36% of 
the women have the positive attitude to health professional counselling as a factor influencing 
their choice of contraceptive methods.   
 
The major factors identified as influencing the choice of contraceptive methods in these 
women include: pregnancy desires and intentions; counselling by health professionals; the 
contraceptive methods available at the nearest PHC, the side effects of the contraceptives and 
the convenience and comfortability associated with the methods; the use or non-use of 
HAART, especially the presence of Nevirapine in the HAART regimen; and financial needs 
for child support grants. 
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OPSOMMING 
 
Die navorser het opgemerk dat sekere ongesonde tendense bestaan in die keuse van 
kontraseptiewe metodes deur vroue wie leef met MIV/VIGS in Cofimvaba. Daar is groot 
kommer omdat dit blyk asof daar „n onsamehangendheid bestaan tussen die kennis wat 
oorgedra is aan die vroue oor die gesonde kontraseptiewe keuses en hulle praktiese keuses 
van kontraseptiewe metodes.  Die navorser wil die faktore wat die keuse van kontraseptiewe 
metodes deur die vroue in die gebied beinvloed, identifiseer. Die data is ingesamel met die 
gebruik van „n vraelys en „n beskrywende kwantitatiewe ontleding is gedoen op die data wat 
ingesamel is op die kennis, houding, begrip en gebruik van vroue ten opsigte van MIV en 
kontraseptiewe metodes. 
 
Die bevindinge was, ten spyte van die hoë bewustheid (92%) onder die vroue wie leef met 
MIV/VIGS oor dubbele beskerming as die metode van keuse vir hulle, slegs 4% dubbele 
beskerming beoefen. Die navorsing het ook getoon dat 40% van die vroue nog onbeskermde 
seks beoefen. Slegs 36% van die vroue het „n positiewe houding teenoor professionele 
gesondheidsberading as „n faktor wat hul keuse van kontraseptiewe metodes beïnvloed.  
 
Die belangrikste fatore wat geïdentifiseer is wat die keuse van kontraseptiewe metodes in 
hierdie vroue beïnvloed sluit die volgende in: begeertes en bedoelings van die swangerskap, 
berading deur professionele gesondheidswerkers, die kontraseptiewe metodes wat beskikbaar 
is by die naaste kliniek, die newe-effekte van voorbehoedmiddels en die gerief en 
gemaklikheid wat gepaard gaan met die metodes, die gebruik of nie-gebruik van HAART, 
veral die teenwoordigheid van Nevirapine in die HAART leefwyse en finasiële behoeftes vir 
kindertoelaes. 
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 DEFINITION OF KEY TERMS 
 
CD4 Count- CD4 cells or T-helper cells are a type of white blood cell that fights infection 
and their count indicates the stage of HIV or AIDS in a patient.  
 
Contraception- The deliberate use of artificial methods or other techniques to prevent 
pregnancy as a consequence of sexual intercourse. 
 
Contraceptives- refer to a technique, methods, device or drugs capable of preventing 
pregnancy.  
 
HAART- refers to combination of two or three ARVs prescribed for PLHIV for life-long use 
to reduce the amount of HIV in their blood and improve their CD4 count.  
 
Injectables- These are hormonal contraceptives given as intramuscular injections at certain 
intervals. There are two popular types: Nuristerat, given every 8 weeks and Depo-Provera 
given every 12weeks.   
 
PMTCT- This is combination of treatment regimen given to pregnant PLHIV women to 
prevent them from vertically transmitting HIV infection to their child during pregnancy, 
labour and breastfeeding period.  
 
Teenage Pregnancy- Pregnancy occurring in woman after puberty and up to 19 years of age.  
 
Viral Load- The viral load refers to the actual number of HIV viruses in the blood in a 
PLHIV.      
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 CHAPTER 1 
OVERVIEW AND RATIONALE OF THE STUDY 
                                     
1.1. INTRODUCTION 
It is the prerogative of HIV positive women to plan for pregnancy, plan their family, or avoid 
pregnancy just like any other women. Most contraceptive methods have been considered to 
be safe and effective for HIV positive women (WHO, 2004). Dual protection is defined as 
any strategy that prevents both unwanted pregnancy and sexually transmitted infections 
(STIs), including HIV (Woodsong, 1999). Dual Protection has been advocated as strategy for 
the reducing the risks of unplanned pregnancy, horizontal transmission of HIV to a non-
infected partner, transmission of resistant virus to a partner with HIV infection, and the risk 
of acquisition of other STIs  like Human Papilloma virus and Hepatitis B&C. It includes 
different combinations of pregnancy and STI prevention, such as the consistent use of 
condoms with hormonal contraceptives. It also involves other risk reduction behaviours such 
as non-penetrative sex or abstinence. In South Africa, the predominance of hormonal 
contraceptives, particularly injectables, means that the simplest approach to dual protection is 
through the combination of a barrier method, most commonly the consistent use of male 
condom , with a non-barrier (primarily hormonal) contraceptive (Myer et al, 2002). South 
Africa's reproductive health policies promote dual method use as an important means of 
preventing both unwanted conceptions and transmission of HIV and other STIs (DoH, 1999) 
 
Health professionals have a duty to ensure that PLHIV women in the reproductive                                                                            
age group make proper reproductive choices by counselling patients and offering appropriate 
contraception at the time of HIV diagnosis, HAART initiation and during follow up. 
However, it is still the prerogative of the patient to make their choices by taking into 
consideration various factors and issues at the back of their mind that could influence their 
choices of contraceptive methods.   
 
1.2. BACKGROUND TO THE STUDY 
South Africa is one of the many Sub-Saharan African nations grappling with the public health 
menace called HIV/AIDS. The South African Department of Health National Antenatal clinic 
survey in 2009 showed that about 29.4% of pregnant women are HIV positive (DoH ,2010). 
The South African National Household HIV Survey of 2008 put national prevalence at 10.9% 
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for all South African aged two years and above (HSRC, 2008). The National Household 
survey also revealed a national prevalence rate of 16.9% for all adults between 15-49 years 
who are most sexually active age group range in the population.    The relative vulnerability 
of women to HIV infection is evident from these statistics because the prevalence rates 
amongst women are much higher than men for all age 5-year age group divisions between 15 
and 49 years in the National survey, likewise pregnant women have higher infection rates 
than the general adult.  
 
The province of the Eastern Cape is one of the worst affected provinces in South Africa. An 
estimated 28% of antenatal clinic attendees were HIV positive in 2008 in this province (DoH, 
2009). The researcher works in the Cofimvaba District Hospital which the only hospital is 
serving about 190,000 people of the Intsika Yethu Municipality in the Chris Hani District of 
Eastern Cape .The hospital is 146-bedded and sub-serves 40 primary health clinics (PHC) as 
a referral centre. Majority of the people make use of these public health facilities for varieties 
of clinical services including family planning, obstetrics and clinical management of 
HIV/AIDS and Tuberculosis because about 73% of the people are poor while unemployment 
rate is at 68%. The HIV infection rates in this community average 30% by extrapolation from 
the district infection rates (McCann, 2005).   
 
The researcher has been directly involved in the management of PLHIV women at the ARV 
clinics and maternity section of the hospital in the areas of initiation of both pregnant and 
non-pregnant women on antiretroviral medications, prevention of mother-to-child 
transmission (PMTCT) of HIV, counselling of HIV positive women on ART adherence, 
healthy contraceptive choices, and general strategy for general wellness                                                                                                                         
even while PLHIV are on dual therapy or HAART. These services are delivered in line with 
the objectives South African Antiretroviral Treatment Guidelines in 2010. The objectives the 
programme were to: - Integrate services for HIV, TB, Maternal and Child Health (MCH), 
Sexual and Reproductive Health (SRH) and wellness; Early Diagnosis of HIV infections; 
Prevention of HIV disease progression; Aversion of AIDS-related deaths, Retention of 
patients on lifelong therapy (HAART); Prevent new HIV infections among children, 
adolescents, and adults; and Mitigation of the impact of HIV & AIDS in the populace (DoH, 
2010). A closer examination of these objectives demands that appropriate sexual and 
reproductive health for PLHIV women hinged upon healthy contraceptive choices is of 
fundamental importance to the successful achievement of these set objectives.     
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 1.3. RATIONALE FOR THE STUDY 
The researcher noticed certain trends in the contraceptive choices made by PLHIV women in 
this public health facility which does not seem to favour condom use despite appropriate 
counselling on importance of consistent condom use either as the only method or in 
combination with other methods. Abstinence appeared to be favoured as a means of 
contraception by a number of PLHIV women but a number of them report back in the 
hospital with pregnancy few months after initiation on HAART and ready to carry the baby 
to term. Others make the choice of hormonal contraception only (commonly Injectables) and 
make the choice of Nevirapine-based HAART regimen which have less teratogenic effect 
compared to Efavirenz-based regimen which is suitable for women who don‟t have 
pregnancy plans in the near future. A sizeable number in this category still get pregnant some 
months after starting ARVs. Apparently, there are some insincerities and inconsistencies in 
the contraceptive choices made by some of these women in the researcher‟s hospital.  
 
Against this backdrop, we are faced with a situation whereby PLHIV women in this area 
could form a steady pool for continued vertical and horizontal transmission of HIV. This 
situation may ultimately negate the objectives of the National Antiretroviral treatment 
programme. There appear to be certain factors that inform the choices of contraceptive 
methods adopted by the PLHIV women in this locality and it is a challenge that is worthy of 
investigation. The rationale for this study, therefore, is to attempt to dig deeper and find out 
the factors that influence the choices of contraceptive methods that PLHIV women clients of 
this hospital.   
 
1.4. RESEARCH PROBLEM  
The current approach to the management of PLHIV women in the reproductive age group 
(16-40 years for the purpose of this study) in my workplace is such that we do counselling on 
family planning at the level of diagnosis with HIV, perinatal visits or at initiation of patients 
on antiretroviral drugs. Very frequently, we do re-counsel PLHIV who may have been 
counselled at the level of PHC on appropriate contraceptive methods during follow-up visits 
and at initiation on ARVs in the hospital. The counselling is often done by taking into 
consideration each individual peculiar medical and psychosocial situation.  
 
However, we cannot say whether there is a disjoint between the knowledge we try to impart 
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on the clients and the choices that they make in the final analysis. We do not know whether 
the counselling done seems to send a wrong message to clients that their HIV positive status 
forbids them from having children. Whatever choices that the PLHIV women make on 
contraception, subsequent service delivery end point is mainly at the PHC clinics level.  
 
So we do not know whether certain elements in the approach of the health professionals to 
counselling of PLHIV women on contraception make that influence contraceptive choices 
made by PLHIV women. Or, we do not know whether the choices made by each individual 
are down to certain factors, circumstances surrounding each individual and their perceptions 
of risks of HIV infection or transmission. The problem or challenge here is that we do not 
what are the underlying factors that influence the choice of contraceptive methods amongst 
PLHIV women in the Cofimvaba community area.       
          
1.5. RESEARCH QUESTION                                   
What are the factors influencing the choice of contraceptive methods amongst PLHIV women 
in the Cofimvaba Community area?                                                                          
 
1.6. SIGNIFICANCE OF THE STUDY 
Contraception has been identified as one of the cornerstones of prevention of mother to child 
transmission of HIV. For women who are HIV positive and who wish to stop childbearing or 
space children or have children, healthy choices of contraceptive methods is very important 
in overall management of the patient. The importance of this study is to be able to identify the 
factors influencing the choice of contraceptive methods by PLHIV women in the Cofimvaba 
community area. Identification of these factors could help the health professionals working at 
this facility to have insight into a more holistic approach to management of PLHIV women 
and their family planning needs. The study may reveal certain factors at the level of 
integration of family planning services and antiretroviral treatment by the health 
professionals from the clients‟ point of view. The study also has a potential to reveal certain 
underlying factors that are due to circumstances surrounding each PLHIV women but which 
may be recurrent in many other cases.   
 
Finally, identification of these factors will help in better approach to HIV prevention and 
family planning services, reduce the risk of PLHIV women infecting to both knowing and 
unknowing sero-discordant sexual partners, and reduce the risk of vertical transmission of 
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HIV to children, reduce infant mortality rates from HIV/AIDS, and in the long term reduce 
the incidence and prevalence of HIV in this area.    
 
1.7 AIM OF THE STUDY 
The aim of this study is to identify the various underlying factors that influence the choice of 
contraceptive methods by PLHIV women in the Cofimvaba community area.  
                                               
1.8 OBJECTIVES OF THE STUDY  
 To determine the knowledge, attitude, perception and practice of PLHIV women regarding 
contraception methods.    
 To identify the factors that influences the choice of contraceptive methods. 
 To identify any gaps between their knowledge and practice as described above. 
 To identify possible ways in which the knowledge of the PLHIV women can be aligned with 
their practical choice of contraceptive methods.     
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 CHAPTER 2 
LITERATURE REVIEW 
 
2.1. EPIDEMILOGY OF HIV/AIDS IN WOMEN 
In 2009, UNAIDS estimates that 33.2 million people are living with HIV/AIDS worldwide 
and more than 50% of all adults with HIV infection are women. Nearly 40% of the world's 
HIV-infected women live in Southern Africa, where heterosexual intercourse is the primary 
mode of HIV transmission. Women living with HIV make up 59% of all adults living with 
HIV in sub-Saharan Africa (UNAIDS, 2010). Each year, these women experience over 1.4 
million pregnancies (WHO, 2009). It is estimated that between 50% and 84% of the 
pregnancies is unintended (Laher et al, 2009; Rochat et al 2006; Desgrees-Du-Lou et al, 
2002). Annual incidence of HIV infection in infants via mother to child transmission is about 
350,000 (UNAIDS, 2010).  The South African epidemic is highly feminized as women 
account for 60% of all infected adults and among 15–24 year olds, women account for 90% 
of incident HIV infections (Rehle et al, 2007)   
 
2.2. CONTRACEPTION: A VITAL STRATEGY FOR PMTCT 
Among women living with HIV infection, the provision of contraceptive services to prevent 
unintended pregnancy is a vital but largely neglected strategy to prevent mother-to-child-
transmission (PMTCT) of the virus.  The risk of mother-to-child transmission occurs during 
pregnancy, delivery, and breastfeeding. During pregnancy and labour the risk of transmission 
is 15% to 30%. Breastfeeding through 18 to 24 months increases the overall risk to 30% to 
45% (De Cock et al., 2000). A recent cost-effectiveness study showed that a PMTCT strategy 
focused on increasing contraception use among PLHIV women could avert 30% more HIV-
positive births than prophylactic nevirapine alone, at the same level of expenditure (Reynolds 
et al, 2006).  
 
Another study found that even moderate reductions in the number of pregnancies to HIV 
positive women ranging from 6% to 35% could avert HIV positive births at the same rate as 
the use of ARVs for PMTCT (Sweat et al, 2004).  Another study also revealed that the 
combination of family planning with PMTCT services could prevent nearly as double the 
number of HIV positive births as the use of ARVs-based prophylaxis in countries with high 
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HIV   prevalence rates (Stover et al, 2003). Recent levels of contraceptive use in Sub-Saharan 
African countries are already preventing 173,000 HIV positive births annually, though 
contraception is not widely available in this region. An additional 160,000 HIV positive 
births can be prevented in Sub-Sahara Africa if all women have access to contraceptive 
services (Reynolds et al, 2005). A similar analysis  which focused on PEPFAR countries 
found that contraception prevents a wide range of HIV positive births from as low as 178 in  
Guyana to as much as 120, 256 in South Africa (Reynolds et al, 2005).    
 
2.3. SEXUALITY, FERTILITY AND CONTRACEPTION IN HIV POSITIVE 
WOMEN 
As more than 80% of all women living with HIV and their partners are in their reproductive 
years (Siegel, 2001), many will continue to want children after learning their positive status, 
whether to start a family or to have more children. Others may wish to regulate their fertility, 
so that they can decide whether to try for a pregnancy and when (Delvaux, 2007). In studies 
of women with HIV infection approximately 70% are sexually active, effective contraception 
use is variable, and unplanned pregnancy frequently reported (Magalhaes et al, 2002; 
Hankins et al, 1998; Wilson et al, 1999).  
 
HIV in South Africa is transmitted predominantly through heterosexual sex, with mother-to-
child transmission being the other main infection route. The national transmission rate of HIV 
from mother to child is approximately 11% (UNGASS, 2010).  In South Africa, almost 20% 
of pregnancies are unwanted and an additional 36% are unintended at the time of conception 
(DoH, 2001), highlighting problems in access to and effective use of contraception 
(Morronni, 2006).  Each year an estimated 220,000 women living with HIV in South Africa 
become pregnant. Although coverage of prophylactic antiretroviral therapy to prevent MTCT 
increased from 15% to 73% between 2004 and 2008 (WHO, 2009), recent estimates report 
that over 64,000 infants are infected with HIV via MTCT each year (Barker, 2007). 
Combination antiretroviral therapy became available in South Africa's public sector clinics in 
2004 and by the end of 2008 an estimated 700 000 adults were receiving HAART, an 
antiretroviral therapy coverage of just 31% (WHO, 2009).     
 
2.4. THE CHOICES OF CONTRACEPTIVE METHODS FOR HIV POSITIVE 
WOMEN 
HIV positive women have the rights to make informed choices relating to their reproductive 
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lives which should be devoid of coercion or restriction from child bearing when desired and 
appropriate contraceptive use for family planning (UNFPA, 2004). Women with HIV 
infection, like other women, may wish to plan pregnancy, limit their family, or avoid 
pregnancy. Health professionals should enable these reproductive choices by giving them 
proper counselling and  providing appropriate contraception at the time of HIV diagnosis and 
during follow up (Mitchell, 2004).   
 
In South Africa, varieties of contraceptive methods are available in public health facilities for 
use by PLHIV women. These include hormonal contraception which comes in forms of oral 
contraceptive pills, Hormonal Injectables and Combined hormonal transdermal patches. Both 
the oral contraceptive pills and injectables come in forms of combined 
oestrogen/progesterone preparations and progesterone-only preparations. All these are 
effective methods of contraception available to PLHIV women (Kaida, 2010). A WHO 
publication indicated that there are no restrictions on the use of hormonal contraception by 
HIV positive women, whether pills, Injectables, implants, patches or rings. Women on 
antiretroviral treatment can use them as well (WHO, 2004).  
 
 However, the drug rifampicine, which is used for tuberculosis treatment, may reduce the 
effectiveness of oral contraceptives (Dickinson, 2001), and the limited data available suggest 
that several antiretroviral drugs may either enhance or reduce the bioavailability of steroid 
hormones in hormonal contraceptives (Chu Jet al, 2005).Other methods available include 
intrauterine contraceptive devices (IUCDs) and the use of both male and female condoms 
(WHO, 2004). Amongst all the methods listed, only the condoms are effective in protecting 
against unwanted pregnancy, STIs and HIV as well (Alfonsi, 2005). Latex condoms, if used 
consistently and correctly, are highly effective in preventing heterosexual sexual transmission 
of HIV, the causative agent of AIDS (CDC, 2011). A meta-analysis of epidemiologic studies 
of condom effectiveness revealed that the consistent use of latex condoms provides a high 
degree of protection against heterosexual transmission of HIV (Weller, 2004). Therefore, the 
consistent use of condoms is a well recommended public health strategy, not only for 
preventing HIV transmission, but also for preventing unintended pregnancies (Alan E et al, 
2008).   
 
Recent studies done in South Africa highlighted the preferences of South African women for 
each the contraceptive methods. A study (Phaweni, 2010) done in rural Mpumalanga among 
Stellenbosch University  http://scholar.sun.ac.za
HIV positive women show that family planning methods used were Injectables (54.8%),  
Male Condoms (33.9%), Pills (22%) and  while the female condom is at 14.6%. Another 
study done amongst Xhosa speaking women in rural Western Cape showed that 77.6% of 
them are involved in inconsistent condom use with their male partners (Land, 2007). 
However, dual method use is featured in South Africa's new reproductive health policies as 
an important means of family planning as well as of prevention of infection with HIV and 
other sexually transmitted infections (STIs) especially for HIV positive people (Myer et al 
2002). Dual protection, defined as any strategy that prevents both unwanted pregnancy and 
sexually transmitted infections (STIs), including HIV, is emerging as an important preventive 
approach in reproductive health (Woodsong, 1999). It may include various combinations of 
pregnancy and STI prevention, such as the use of condoms with hormonal contraceptives, or 
it may consist of other risk reduction behaviours such as nonpenetrative sex or abstinence.   
 
In South Africa, the predominance of hormonal contraceptives, particularly Injectables, 
means that the simplest approach to dual protection is through the combination of a barrier 
method, most commonly the male condom, with a nonbarrier (primarily hormonal) 
contraceptive (Myer, 2002). South African reproductive health policies promote dual method 
use as an important means of preventing both unwanted conceptions and transmission of HIV 
and other STIs (DoH, 1999).  A study done in the Western Cape revealed that the frequency 
of dual-method use is low among sexually active women attending public health facilities in 
the Western Cape, with 33% of women reporting having ever used dual methods during 
sexual intercourse and 10% currently using dual methods (Morronni et al, 2006).    
 
2.5. FACTORS INFLUENCING THE CHOICE OF CONTRACEPTIVE METHODS 
IN HIV POSITIVE WOMEN  
Contraception use and compliance is dependent on the range of methods available, patient 
choice, prevalent health and religious beliefs, perceptions of method effectiveness, and side 
effects. For example, some women may be less tolerant of heavy and prolonged vaginal 
bleeding than amenorrhoea which will make them prefer the amenorrhoeic side effects of 
Injectables (Bongaarts, 2000; Playle, 2000; Imbuiki et al 2010). Correct use of most user 
dependent methods like OCP and condoms requires a basic knowledge of reproduction and 
literary know-how to follow written instructions (Gazmararian et al 2002). In many countries 
(South Africa inclusive) women are unable to make autonomous decisions about their sexual 
and reproductive health because economic dependence, and established cultural or religious 
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attitudes to women‟s rights (UNAIDS 1999). The French SEROCO study on the impact of 
HIV diagnosis on sexual and contraceptive behaviour found that of the sexually active 
women, 20% were using no contraception, 24% became pregnant, and 63% of pregnancies 
ended in abortion (De Vicenzi et al, 1997).  In the African DITRAME Project, 39% of 
PLHIV women used contraceptives; factors significantly related to contraceptive use were 
marital status and level of education (Desgrees-Du-Lou et al, 2002) 
 
There are different factors that have been listed as influencing choice of contraceptive 
methods in HIV positive women. Accessibility to healthcare services, availability of 
contraceptive methods and their cost are important factors especially for rural women in 
resource poor settings ((Harries et al., 2007). The religious, cultural, and personal beliefs of 
the women are also important factors influencing choice of contraceptive methods. The 
biological and cultural role of women in society is such that women are expected to procreate 
irrespective of their HIV status (Cooper et al, 2005). Certain religious beliefs abhor the use of 
condoms while some other religions forbid contraception of any kind.   
 
Another factor is the acceptability of the method to the partner of the woman. This is more in 
the case of condom use whereby most times women are not able to negotiate condom use as 
they may be perceived as being promiscuous. In some cases many men are unwilling to use 
condom because it is perceived is reducing sexual pleasure and somewhat cumbersome 
(UNDP/UNFPA/WHO/World Bank, 2002; Imbuiki et al., 2010). The effects of contraceptive 
method on menstruation is also another factor that can influence choice of contraceptive 
method (Imbuiki et al., 2010).   
 
The HIV status of a woman including the CD4 count, viral load, and general physical 
wellbeing can influence the choice of contraceptive method (Stanwood, Cohn, Heiser & 
Pugliese, 2007, Imbuiki et al, 2010). The level of knowledge received about healthy choice of 
contraception at family planning counselling may also influence the choice. PMTCT 
knowledge of the HIV positive woman may also influence the choice of contraceptive 
method. Another important factor is whether the woman has disclosed her status to the 
partner or not (Peltzer, Chao and Dana, 2008; Kaida et al, 2010). The HIV status of the 
partner of the woman may also have an influence on contraceptive choices. This is dependent 
on whether the partner‟s status is known or not and also on whether it is concordant or 
discordant (Myer et al., 2002).   
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 Reproductive health guidelines that are available are ambiguous on whether or not pregnancy 
among HIV positive couples is advisable. They rely heavily on the counselling services that 
allow clients to make autonomous decisions. This uncertainty creates grey areas which allow 
health care providers to impose their own ideals, values and attitudes about what are right for 
clients (London, Orner and Myer, 2008). According to London et al. (2008), these provider‟s 
values and attitudes may significant impact on the effectiveness of non-prescriptive 
guidelines, especially where social norms and stereotypes about childbearing are powerful. 
Health providers could be torn between divided loyalty pressures with negative effect on the 
rights of clients and eventually the decisions they will make on the choice of contraceptive 
method. 
 
There are few studies (Cooper et al., 2005; Cooper et al., 2007; Laher et al, 2009; Peltzer, 
Chao and Dana, 2008, Imbuiki et al., 2010) that highlighted the pregnancy desires or fertility 
intentions of the women or their partners as a factor influencing the choice of contraceptive 
methods used by PLHIV women. A study (Peltzer, Chao and Dana, 2008) conducted in the 
Eastern Cape of South Africa investigated family planning needs, knowledge of HIV 
transmission and HIV disclosure among 116 HIV-positive women and 642 HIV-negative 
women. Although, all women had received counselling on safe sex during pregnancy, only 
65.8% of the HIV positive women practiced safe sex. During the postnatal period almost all  
women received counselling on family planning, yet the use of contraceptives and condoms 
were low. Among HIV-positive women, PMTCT knowledge and the younger age of the 
mother were linked with pregnancy desire. Studies within and outside South Africa has 
suggested that many PLHIV women continuously desire pregnancy despite their awareness 
of their HIV status (Delvaux, 2007; Phaweni, 2010; Farlane, 2010). Another study done on 
HIV positive women (HAART-users and HAART-naive) and HIV negative women between 
ages of 18-44years in Gauteng revealed that about 45% of them have desires to be pregnant. 
HAART users were more likely to use dual protection (68%) compared to 58% in HAART 
naive women (Kaida et al., 2010). In this study, contraceptive use was associated with 
younger age, having two or more living children, and expressing an intention not to have 
(more) children also remained significantly associated with contraceptive use. In a study 
(Phaweni, 2010) done in Mpumalanga amongst non-pregnant HIV positive women, bivariate 
analyses of data revealed that; lower age, no child or fewer number of children, had resumed 
sexual relations, knowledge of PMTCT, had discussed family planning at postnatal care visit, 
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had received information on future fertility, had shared HIV test results with the mother, 
current partner was aware of HIV status, and knowing the HIV status of their baby were 
associated with pregnancy desire.  
 
Multivariate analyses of the data in this study by Phaweni in 2010  also showed that; no child 
or fewer number of children, had discussed family planning at postnatal  care visit, current 
partner was aware of HIV status, and knowing the HIV status of their baby were associated 
with pregnancy desire. And all these could play important role in the decision to use 
contraception and the choice of the method to be utilized for family planning. One other 
factor the researcher will seek to explore is whether the Child Support grants (CSG) could be 
influencing the choice of contraceptive methods by PLHIV women especially in one of the 
poorest provinces in the country. There have been no studies done locally in this direction but 
a study was done on the influence of CSG on teenage fertility rates in South Africa 
(Makiwane et al., 2006). A school of thought developed in South Africa which claimed that 
the CSG has some perverse incentives, one of which is to encourage women to have more 
children, especially teenagers (PPASA, 2003; Hashim, 2005). When the SA government 
increased the age of the CSG beneficiaries from 7 years to 14 years in 2004, the number of 
beneficiaries from the scheme increased.  
  
During that period the teenage fertility rate increased relative to other age groups, with the 
highest teenage pregnancy rate reported in Eastern Cape and Limpopo provinces (Statistics 
SA, 2005). The analysis of the study (Makiwane et al., 2006) concluded that there was no 
relationship between age specific teenage fertility rate and increased amount of child support 
grants through quantitative analysis of some data. A study (Panday et al, 2009) done in the 
Eastern Cape, showed the HIV prevalence is higher among school aged youth than adults and  
that the province has the highest teenage pregnancy rate (68.81 pregnant pupils per 1000 
registered ) in the country . This showed that there might be a link between teenage 
pregnancy rate, contraceptive choices and HIV prevalence rates in the Eastern Cape. 
However, the researcher will try to find out if the child support grant has strong link and 
influence on the choice of contraception and the teenage pregnant rates.  
 
Other factors that can influence the choice of contraceptive methods amongst PLHIV women 
are clinical factors. They will not be the focus of this study. However, the researcher will like 
to make mention of them.  These factors are: Menstrual, Sexual, and Reproductive history 
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such as menorrhagia, dysfunctional uterine bleeding dysmenorrhoea, past pelvic infection, 
past ectopic pregnancy; Medical history such as abnormal liver function, past history of 
venous thromboembolic disease, hypertension, hyperlipidaemia, current drug abuse; and 
Medications like Enzyme inducers, antibiotics, and teratogenic agents.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stellenbosch University  http://scholar.sun.ac.za
 CHAPTER THREE 
RESEARCH METHODOLOGY 
 
3.1. INTRODUCTION    
The purpose of this study is to identify the factors that influence the choice of contraceptive 
methods amongst PLHIV women in the Cofimvaba area. These factors are currently not 
completely understood. In view of this, a quantitative research approach will be adopted for 
the purpose of this study to collect some type of numerical data in order to answer the 
research question.    
 
3.2. RESEARCH DESIGN   
The design is a descriptive type of research in which the goal is to attempt to identify 
variables that exist in a given situation or attempt to identify causal relationships. It a type of 
research technique frequently used to determine knowledge, attitude, beliefs, perception, and 
practices for the purpose of a particular decision making (Christensen, 2004). In this study, 
the decision making is the choice of contraceptive methods by PLHIV women. The 
researcher sought to determine the factors influencing their decisions regarding choice of 
contraceptive methods by exploring their knowledge, attitude, practices, beliefs and practices 
about HIV transmission and family planning.  
 
3.3. DATA SOURCES  
Data were obtained from the hospital files, maternity case records and responses of 
consenting participants to the questionnaire designed for this study. Pertinent data obtained 
from participants records were to confirm the current type of contraceptive method adopted 
by individual participants and also to obtain the HAART regimen of participants who are 
currently using life-long ARVs. 
 
3.4.DATA COLLECTION 
 The survey was conducted using a questionnaire which consists of certain number of closed-
ended questions (about 29) and opened ended questions (about 7), apart from the first section 
that obtained basic information on the bio-data of the participants. Participants      were made 
to answer Yes or No to the closed ended questions and also to take the option „Don‟t Know 
where they don‟t know or they are not sure. The questionnaires were                                                                             
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self-administered or via interpretation by a delegated trustworthy Xhosa-speaking nurse in 
the ARV unit because the researcher is not fluent in Xhosa language. The themes that were 
be covered will be demographic characteristics of the respondents, general knowledge about 
HIV transmission and family planning; attitudes towards contraceptive methods and 
disclosure of HIV status, fertility intentions and HIV transmission to child and partners; 
perceptions about contraceptive methods, family planning counselling and methods; and 
beliefs and practices around HIV transmission and contraceptive methods. The questionnaire 
was piloted and the findings put into consideration in the administration of the questionnaire 
while conducting the research proper.  
 
3.5. POPULATION AND SAMPLING 
The population sampled by the researcher for the purpose of this study are non-pregnant 
PLHIV women between 16 and 40 years of age attending Cofimvaba Hospital. A stratified 
sampling method was used to select a sample size of about 60 respondents but ensuring there 
is an even or near even distribution of numbers between a set of 5-year age ranges. This age 
ranges will have 12 respondents selected for ages 16-20, 21-25, 26-30, 31-35, and 36-40 
years. However, only 50 questionnaires were satisfactorily returned for the purpose of data 
analysis.  
 
3.6. DATA ANALYSIS  
This research is quantitative. For the purpose of analysis, conversion of the responses 
obtained to numerical values was instituted. The data were captured and coded in Excel 
spread sheet and further analyses of data were done using the statistical functions available on 
Microsoft Excel.   
 
3.7. ETHICAL ASPECTS 
 A written and documented permission was obtained from the hospital management for the 
purpose of conducting this study. Ethical clearance was sought and obtained from the 
Research Ethics Committee of Stellenbosch University. The research was given a protocol 
number HS 725/2011 on approval. Participation was voluntary. Each participant was made to 
sign a consent form obtained and modified from the university website. The process of data 
collection ensured no psychological damage was done to participants and that the researcher 
emphasised the study is not meant to be judgemental of any participant. Participants were 
informed they are allowed to withdraw if they so which. However, participants were assured 
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of all confidentiality of the information obtained from them and their hospital records. The 
names of participants were neither written on the questionnaires nor the consent form in order 
to maintain anonymity of the participants. Instead, each participant was allotted study 
identification number. Data collected was kept secret and safe all the time by the researcher.  
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 CHAPTER 4 
FINDINGS AND DISCUSSIONS 
 
The data collated from the demographics of a quantitative research survey is of fundamental 
importance to finding some association between certain variables and factors in a study 
because there may be interlinks between certain demographic parameters and certain set of 
knowledge, attitude or practical behaviour in relation to certain life issues. We shall begin our 
findings from the demographic data obtained from this study.  
 
The majority (72%) of the PLHIV women were never married while 75% of those are age 30 
years or below (FigureA.2). There is high unemployment rate (66%) amongst the PLHIV 
women, coupled with the fact that 8% of those aged above 20 years have never worked. The 
unemployment rate could said to be about 74% (Figure A.3) amongst the PLHIV women. 
This is not far from the unemployment rate (68%) in the general population in the study by 
McCann, 2005. The financial means of living by those unemployed or who have never 
worked are majorly through social grants. At least 82% of them are dependent on one form of 
social grant or the other. Figure A.4 showed that 52% and 15% of them are dependent on 
child support grants only and disability grants only, respectively. McCann (2005) had 
revealed that poverty rate in this district is at 73%. This is also corroborated by the population 
in this study. At least 78% of the study population have an average household monthly 
income of R1000 or less (Figure A.5).   
 
The essence of this study to investigate choices of contraceptive methods in PLHIV women is 
recognition of the sexuality of the HIV positive woman. Therefore, it was necessary to know 
how sexually active our subjects could be. In this study, 98% of the subjects have at least one 
sexual partner within the last one year while 16% of them have at least 2 sexual partners 
within the last one year (Figure A.6). No doubt, PLHIV women in this area sexually active as 
exemplified in other studies (Magalhaes et al, 2002; Hankins et al, 1998; Wilson et al, 1999).  
The use of HAART and having two or more children has been associated with contraceptive 
use (Kaida et al, 2010). It is imperative know the demographics along these parameters. In 
this study, 88% of participants are currently using HAART (Figure A.7a) but only 44% 
(Figure A.8a) have two or more children. In the build-up to the research problem of this 
study, the researcher expressed concerns that the frequent presence of the drug- Nevirapine in 
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the HAART regimen of the HAART-using PLHIV women in this area has not been 
consistent with their contraceptive choices. The Nevirapine is made available usually for 
women who have future pregnancy desires and as such will engage in unprotected sex. This 
antiretroviral drug has lesser tendencies to cause deformities in the developing baby, 
especially in the first trimester of pregnancy.                                    
                      
The goal of using nevirapine, therefore, is to give rest of mind to the woman that if she does 
get pregnant there will be no fear of the baby having deformity as opposed to using Efavirenz 
(common substitute for Nevirapine) which is commonly used by men and by women with no 
future pregnancy desires. However, this study revealed that 61% of the participants are 
currently using Nevirapine-containing HAART regimen (Figure A.7b). We shall correlate 
this with their contraceptive choices and future plans for pregnancy in the later part of this 
discussion. The study sought to test the knowledge of the participants about HIV 
transmission, prevention of HIV infection, methods of contraception and established factors 
influencing choice of contraceptive methods as highlighted in Chapter 2. The knowledge of 
PLHIV women in this study about how HIV is transmitted is at an average 78% (Figure B.1).  
This is quite impressive. However, their knowledge score on vertical transmission of HIV 
from pregnant mother to the unborn child is a bit below par (56%) and is the least score of all 
the possible means of HIV transmission. This is a gap in the knowledge of the PLHIV 
women about HIV transmission because vertical transmission is the second most important 
means of HIV transmission in South Africa (UNGASS, 2010).As shown in Figure B.2, their 
knowledge about how HIV infection is excellent at an average score of 75%. What is worthy 
of note is that between 60-70% of them know that injectables and oral contraceptive pills do 
not prevent HIV transmission. The subjects were asked to mention every type of 
contraceptive method that they know. Figure B.3 revealed that the most frequently known 
contraceptive method is the injectables (76%), followed by Condom (66%) and then OCP 
(30%).  
 
Interestingly, 10 % of them mentioned Abstinence as a method of contraception but in a 
population of women are 98% sexually active abstinence may not be a popular option for 
them. None of the participants directly mentioned hormonal skin implants and bilateral tubal 
ligation as methods of contraception. This did not come as a surprise because in a resource 
poor settings like where this study was done, those two methods are not frequently offered to 
clients. Only 4 % could mention the four most frequently available methods combined 
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together at once (Condom, OCP, injectable & IUCD). However, the IUCD mentioned by 8% 
of them, was only introduced in the second quarter of this year by the provincial government 
as part of the strategy to reduce teenage pregnancy rates in the area.  
 
The condom as a contraceptive method for simultaneously preventing pregnancy, HIV and 
other STIs (Alfonsi, 2005) is known by 80% (Figure B.4). Only 74% of them (Figure B.5) 
know about dual protection as the preferred choice of contraceptive method (Myer et al 2002)  
despite the fact that 90% of the subjects (Figure B.8) acknowledge that they had received 
counselling from health professionals about dual protection as promoted by the government 
(DoH, 1999). Through re-infection, increased viral load and introduction of drug resistant 
strains of the HIV virus, 92% of the participants agreed that the health of the HIV positive 
woman could be worsened if she continues to have unprotected sex with infected partner(s) 
(Figure B.6).                  
                                                                      
In the last part of the knowledge test, the study sought to determine the level of knowledge of 
the participants about established and known factors that influence the choice of                                                                                                        
contraceptive methods as described in Chapter 2 of this project. However, the researcher 
decided to skew in a few other factors that PLHIV women in the area may be aware is 
existent in the area but which are not yet generally known. These factors include: fear of 
stigmatisation or discrimination by family or friends, fear of stigmatisation by health 
professionals and financial needs for CSG. The six most known factors influencing the choice 
of contraceptive methods are counselling by health professionals (84%), side effects of the 
contraceptive methods (78%), financial needs for child support grants (76%), access to or 
availability of the contraceptive method at the nearest clinic (74%), pregnancy desires or 
intentions (70%) and the use or non-use of HAART (70%).(Figure B.9). A considerable 
fraction of the women also responded positively that they know that fear of stigmatisation by 
health professionals (62%) and fear of stigmatisation by family of friends (56%) may 
influence the choice contraceptive methods by PLHIV women. 
 
In the Section C, the attitude and perception of the PLHIV women were examined in relation 
to contraceptive methods and factors influencing choice of contraceptive methods. The 
respondents were asked which contraceptive method(s) do each of them think or feel is the 
most appropriate for her, by looking at their individual circumstances. The response was that 
only 8% of them are favourably disposed to the use of dual protection despite 90% of them 
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being counselled on dual protection. About one-third of the study population feel they are 
favourably disposed to using methods that amount to unprotected sex while 62% feel they 
could be okay using condoms only (Figure C.1).  
 
Nevertheless, 48% of our study population feel that pregnancy desire and intentions may 
influence their choice of contraceptive method (Figure C.2) as highlighted in some studies 
(Cooper et al., 2005; Cooper et al., 2007; Laher et al, 2009; Peltzer, Chao and Dana, 2008, 
Imbuiki et al., 2010). In Figure C.3, 42% feel that the state of being sick or healthy may 
influence their choice of contraceptive method (Stanwood, Cohn, Heiser & Pugliese, 2007, 
Imbuiki et al, 2010). In Figure C.4, 40% of the PLHIV women feel or think that family, 
social or cultural pressures that a woman must bear children could influence their choice of  
contraception (Cooper et al, 2005).  
 
In figure C.5, only 36% of the study population feels that health workers counselling may 
influence their choice of contraceptive method (Peltzer, Chao and Dana, 2008; Kaida et al, 
2010) despite 84% of  them knowing that health workers counselling is factor that can 
influence the choice of contraceptive method. This is of serious concern and it all boils down 
to the fact that not all appropriate knowledge and values impacted on individuals by health 
workers on how to handle their reproductive lives results in appropriate attitude towards that 
healthy contraceptive choices (London et al, 2008). Interesting as well, 36% of the women 
feels that health workers attitude and approach to counselling could influence their choice of 
contraceptive method (Figure C.6).   
 
According to Harries et al, 2007, accessibility and availability of contraceptive methods in 
health care services centres is a considerable factor that can influence the choice of 
contraceptive methods especially in resource poor settings like where this study was 
conducted.  In this study, 44% of the women (Figure C.7) feel that the contraceptive methods 
available at their nearest health centre or clinic may be able to influence their choice of 
contraceptive methods.  
 
Another factor that may influence the choice of contraceptive method is the acceptability of 
the method to the woman‟s male sexual partner especially when it comes to the use of 
condom which is perceived by men as reducing sexual pleasure or could mean their women 
are promiscuous (Imbuiki et al., 2010). In this study (Figure C.8), 66% of the women feel that 
Stellenbosch University  http://scholar.sun.ac.za
their male partner may not influence their choice of contraceptive method. Likewise, 58% of 
the women feel that the fear of being stigmatised by their male partner may not influence 
their choice of contraceptive methods (Figure C.15). It will be encouraging that the larger 
percentage of the women may be able to stand up to their men on their choice of 
contraceptive especially if it has to do with the choice of condom. But does this attitude really 
translate to behaviour? We shall see later in this discussion. 
 
Another important factor that may influence the choice of contraceptive method is whether 
the woman has disclosed her HIV positive status to the partner or not (Peltzer, Chao and 
Dana, 2008; Kaida et al, 2010). There are women (42%) in this study who feel whether or not 
disclosing their status to their sexual partner could influence their choice of contraceptive 
method (Figure C.9).Furthermore, 38% of the women agree with study by Myer et al in 2002 
that they feel the HIV status of their sexual partner (either positive or negative) could affect 
their choice of contraceptive method (see Figure C.10). This will be dependent accordingly 
on whether the status of their partner is known and whether it is discordant or concordant.  
 
The social and welfare burden created by HIV in our society is well known. The HIV positive 
woman could be a burden to her family or friends when she is sick and if she dies, the 
children she leaves behind could become secondary socio-welfare burden to her family. So 
the reproductive lives of HIV positive women will be of concern to their family or friends 
and she might get stigmatised if they found out she is making contraceptive choices that 
could mean more welfare „burden‟ for them. In Figure C.11, 36% of our study population feel 
the fear of stigmatisation by family or friends could affect their choice of contraceptive 
methods. This factor will be dependent on how much support each individual gets from 
family and (or) friends on their reproductive lives.  
 
According to London, Myer and Orner in 2008, there are uncertainties in reproductive health 
guidelines about pregnancy in the HIV positive woman and there is a tendency for health 
professionals to impose their own ideals, attitudes and values on their clients. Often, it may 
result in health professionals advising HIV positive woman not to get pregnant because they 
know that she can infect her partner and the baby in the process. In Figure C.12, 32% of the 
PLHIV women acknowledge that they have perceived things in the attitude of health workers 
during counselling that suggest HIV positive women should not bear children. This means 
that certain of health professionals in the area have found themselves in the same situation 
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described by London et al.    
Moreover, respondents were made to mention the side effects they might have felt with any 
contraceptive methods they used. In Figure C.14, majority (58%) have felt no side effects 
before now. 50% of this group are currently using condoms only and 6.25% are currently 
using dual protection. The individuals who felt amenorrhoea or irregular menses are currently 
using injectables. These are common side effects of the Injectables. And it is no surprise that 
three-quarter of those who are currently using no contraceptives has had vaginal discharges. 
Vaginal discharge is a symptom of many sexually transmitted infections. In Figure C.13, 26 
% of the women feel that the side effects of the contraceptive methods could affect their 
choice of contraceptive method while 66 % of them said no. However, in a study population 
where some have never felt a side effect with their contraceptive method or where the 
amenorrhea experienced commonly with the popular injectables is a desirable side-effect, a 
response of this nature is not far-fetched.  
 
An average 36% of the respondents think or feels that the factors mentioned (in Section C, 
Questions 2-13 and 15) could influence their choice of contraceptive methods. This is shown 
in Table C.16 and Figure C.16. Their attitude and perception to these factors, on the average, 
appear to be the reverse compared to their knowledge on those factors. However, attitude and  
perception is an individual thing, each individual is not expected to feel that majority of the 
factors could influence her choice of contraceptive method. So it will be down to each 
individual circumstance and (or) situation. It must be emphasized that identification of the 
gap between their knowledge and attitude is not one of the objectives of this study; therefore, 
the researcher would not delve too much into that.   
 
The final part of the findings and discussions will be on the practice and behaviour of our 
participants on issues around their contraceptive method of choice and their HIV status. The 
participants were asked which contraceptive methods they are using now. In Figure D.1, there 
are 56% using condoms only, 28% are using injectables only, 4%  are using OCP only, 2% 
using IUCD, 4% are using condoms and injectable (dual protection) while  6% are using no 
contraceptives. Overall, only 60% of the participants in this study are having protected sex 
while 40% are still having unprotected sex despite the fact that 92% of them know that their 
health condition could get worse if they continue to have unprotected sex and 80% of them 
knowing that the use of condoms offers prevention of HIV infection, pregnancy and STIs.  
This outcome is similar to the study done in the Eastern Cape in 2008 by Peltzer, Chao and 
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Dana where only 65% of the women practising safe sex. In this study, there are gaps between 
the knowledge (90%), attitude (70) % and behaviour 60% of the participants when it comes 
to practising safe sex. Similarly, only 4% of the participants are practising dual protection 
whereas 92% of them have received counselling on dual protection as a preferable 
contraceptive method of choice for HIV positive women and 8% of them having positive 
attitude to the use of dual protection. This level of use of dual protection amongst this mostly 
HAART using women is a far cry below the 65% in the study (Kaida, 2010) done in 
Gauteng.  
 
The researcher sought further to find the reasons for their choice of contraceptive methods. 
There are three participants who are using no contraception. Two of them gave their reasons 
as intending to get pregnant and one said she has no sexual partner for now.  The first two in 
this group emphasizes pregnancy desires or intentions as one of the factors influencing the 
choice of contraceptive methods (Cooper et al., 2005; Cooper et al., 2007; Laher et al, 2009; 
Peltzer, Chao and Dana, 2008, Imbuiki et al., 2010) Amongst the two that are using OCP, one 
of them gave her reason that she wants her menstruation to be regular again which could be a 
therapeutic effect OCP can offer either from the irregular menses occurring from side effects 
of using OCP or from primary dysfunctional uterine bleeding. The other OCP-only user gave 
her reasons as being “satisfied and comfortable” with the Pills. This is the same reasons given 
by three out of the fourteen injectables-only users. Similarly, another three of the fourteen 
injectables-only users gave their reasons as – “the 2-3 months interval is convenient and easy  
to remember”. Also, one condom-only user gave her reason for using condoms as “easy to 
use”.   
 
From these foregoing, I can safely say that on the factors influencing the choice of 
contraceptive methods in PLHIV women in this study is the ease, convenience, 
comfortability and satisfaction with the method. Still amongst the injectables- only user, one 
of them gave her reason for using it as “to gain weight and look healthier”. The general state 
of health of this subject is influencing her choice of contraceptive method. Another gave her 
reason for using injectables as “don‟t want to lose blood through menses” (prefers 
amenorrhoea). Weight gain and amenorrhoea are side effects of Injectables and this means 
they prefer the side effects of the injectables as corroborated in other studies (Bongaarts, 
2000; Playle, 2000; Imbuiki et al 2010). The only IUCD-only user in this study gave her 
reason that the method “has no side effects and can stay for 5 years” and one of the condom 
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only users gave her reason as “no pains”. At this point, it is suffice to say that one of the 
factors influencing the choice of contraceptive methods in these women is the side effects of 
the contraceptive methods just as in other studies (Bongaarts, 2000; Playle, 2000; Imbuiki et 
al 2010).  
 
Another interesting reason given by one of the injectable-only users and one of the condom 
plus injectable user is “don‟t want to get pregnant in case of a rape. Apparently, the fear of 
rape and getting pregnant after a rape is a factor influencing their choice of contraceptive 
method. The injectable being “the method available at the nearest clinic” was given as a 
reason for her choice of the injectables by another injectables-only user. This is just as 
described as a factor influencing the choice of contraceptive methods by women in resource 
poor setting by Harries et al (2007). One other injectable-only user gave her reason as to 
“prevent pregnancy for now and have a baby later” while one of the condom-only users gave 
her reason as- “can decide to have a baby later”. These strengthens the fact that safe sex or 
not, pregnancy desires and intentions is a factor influencing the choice of contraceptive 
methods (Cooper et al., 2005; Cooper et al., 2007; Laher et al, 2009; Peltzer, Chao and Dana, 
2008, Imbuiki et al., 2010) amongst PLHIV women in the Cofimvaba area. 
 
There are, however, those who gave reasons which are in line with the knowledge acquired 
from counselling obtained from health professionals about healthy contraceptive choices. The 
“condom prevent STIs” were the reason given by the two dual protection users and 12/28 
(43%) of the condom-only users. Another reason was to “prevent getting more HIV 
infection” was given by 8/28 (29%) of the condom-only users. “Do not want to infect my 
partner” as a reason by 8/28 (29%) of the condom-only users. Lastly, 15/28 (53%) of the 
condom-only users gave their reason as- “to prevent getting pregnant and having a baby born  
with HIV”. This is also the reason given by 4/14 of the injectables-only users (Figure D.2e). 
It must be borne in mind that some of the condom-only users gave more than one reasons 
(Figure D.2f).   
 
The findings here are in line with other studies (Peltzer, Chao and Dana, 2008; Kaida et al, 
2010) that the level of knowledge received about healthy choice of contraception at family 
planning counselling and PMTCT knowledge of the HIV positive woman can influence her 
choice of contraceptive method. Overall, 56% of the women in this study have the knowledge 
of PMTCT but only about 40% are actually practicing their contraception with a view to 
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reduce mother-to-child transmission of HIV. In this study as well, 92% of the women know 
that re-infection with HIV can increase viral load of the woman, cause infection with drug-
resistant strains of HIV and worsen their health condition but only 16% of them were making 
their contraceptive choice with a view to prevent HIV re-infection. In summary, there are 
gaps between the knowledge of the women and their practice when it comes to vertical 
transmission of HIV and horizontal transmission of HIV.   
 
Next up, is the question of how consistent the PLHIV women use their individual choice of 
contraception. Amongst the 28 condom-only users, only 2/28 (7%) reported not using the 
condom consistently. Likewise, 1/14 (7%) of the injectables-only users reported not using her 
method consistently. Other people use their methods consistently (Figure D.3). “No reason” 
was given as the reason for the inconsistency of the 3 women. Another behaviour which was 
examined was if the women have disclosed their HIV status to their partners, 84% have 
disclosed their status to their partners (Figure D 5-8). This might explain why the women 
were more likely (52%) to feel that the disclosure of their HIV status to their partners could 
not affect their choice of contraceptive method. Also, 78% of the women have made partner 
get tested for HIV (Figure D 5-8). Likewise, this may explain why the women were more 
likely (56%) to feel or think that the HIV status of their partner may not affect their choice 
contraceptive methods. In a similar vein, 88% of the women said that they can insist their 
partners should use condom (Figure D 5-8). This may also explain why the women were 
more likely (66%) to feel that pressure from their male partner could not affect their choice of 
contraceptive method. Though, there is a gap of 28% between those who can insist on 
condom use by their partner and those who are actually using condoms.   
 
The researcher has mentioned in the literature review that studies within and outside South 
Africa has suggested that PLHIV women continue to desire to be pregnant despite knowing 
their status (Delvaux, 2007; Phaweni, 2010; Farlane, 2010). This study agrees with the 
aforementioned because the subjects were asked if they have plans to have more children. 
What came out was that 46% of the subjects have plans to have more children (Figure D5-8).  
 
This reinforces other studies (Cooper et al., 2005; Cooper et al., 2007; Laher et al, 2009; 
Peltzer, Chao and Dana, 2008, Imbuiki et al., 2010) that highlighted pregnancy desires or 
fertility intentions of PLHIV women and their male partners as a strong factor that influence 
the choice of contraceptive methods by these women. Of those (23/50) who said that they 
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have plans for more children, 43% of them conceded that their fertility intentions influenced 
their choice of contraceptive method (Figure D.9). Further analysis of this group showed that 
74% of those who have future pregnancy plans are aged 30years and below (Figure D.8a). 
 At the same time the research revealed that 19/23 (82%) of those who have pregnancy 
desires have less than 2 children alive (Figure D.8b). These findings is in tandem with the 
study in Mpumalanga by Phaweni in 2010 that revealed that lower age and no child or fewer 
number of children were associated with pregnancy desires amongst PLHIV women. In 
Figure D.8c, the researcher sought to analyse the HAART regimen of those who have plans 
for more children and it showed that 65% of them are using nevirapine-based HAART 
regimen while 13% of them are yet to be on HAART at all. This showed a strong association 
between the use of Nevirapine-based HAART regimen and intention to be pregnant amongst 
the PLHIV women. It also means that the presence or absence of Nevirapine in the HAART 
regimen of PLHIV women is a factor influencing their choice of contraceptive methods. 
Lastly, the group of women were made to answer if the benefit of getting child support grants 
has a link to their future pregnancy plans. In Figure D.10, (12/23) 52% of them answered yes. 
Overall it means that 12/50 (24%) of the women in this study can be said to have the 
incentive of child support grants as reason for their fertility intentions and by extension CSG 
is a factor that influences their choice of contraceptive method. And this cannot be said to be 
out of place in study population that has 60% wholly or partially dependent on CSG for their 
financial needs.   
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 CHAPTER FIVE 
CONCLUSIONS AND RECOMMENDATIONS 
 
5.1. CONCLUSIONS 
 The conclusions that will be made from this study will be to see how much the objectives of 
this study have been achieved. The first of the objectives was to determine the knowledge, 
attitude, perception and practice of the PLHIV women about contraception methods and the 
third objective was to determine the gap between their knowledge and practice. The 
knowledge displayed can be said to be outstanding. Their knowledge score on HIV 
prevention and transmission averages 78% and 75% respectively. The most commonly 
known methods of contraception were condoms (76%), injectables (66%) and OCP (30%). 
Abstinence was also given recognition as a contraceptive method (10%).  
 
The IUCD was not well known (8%) and neither was mention made of hormonal transdermal 
implants nor bilateral tubal ligations (surgical contraception). It appear the reason for this 
scenario is because the participants made mention of those method that are readily available 
at their PHC. The condom was also well known (80%) as the method that can prevent STI, 
HIV and pregnancy but only 70% have the right attitude to the use of condom while the 
practical use of condom is limited to 60% of the participants. About 90% of the women have 
received counselling on dual protection as the method of choice for sexually active, 75% 
know actually that dual protection is the preferred contraceptive method sexually active HIV 
positive women but only 8% of them have positive perception to the use of dual protection. 
In practice, only 4% of them are practising dual protection.  
 
There is a big gap between their knowledge, attitude and practice on contraceptive methods. 
In study population that is 98% sexually active, it is worrisome that 40% are engaged in 
unprotected sex. And in a situation like this, there will be high tendency for increased 
incidence and prevalence of HIV infection through vertical and horizontal transmission of 
HIV by these PLHIV women in this community. The health professionals are not winning the 
fight to popularise dual protection at all. The method is as good as non-existent.                
                                                 
The major factors that have been identified as influencing the choice of contraceptive 
methods in these women include: pregnancy desires and intentions; counselling by health 
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professionals; the contraceptive methods available at the nearest PHC, the side effects of the 
contraceptives and the convenience and comfortability associated with the methods; the use 
or non-use of HAART, especially the presence of Nevirapine in the HAART regimen; and 
financial needs for child support grants. Other factors that featured prominently include: 
family, social, cultural pressures that a woman must have children; pressure and fear of 
stigmatisation by male partner; fear of stigmatisation by family or friends; attitude and 
approach of health professionals to family planning counselling; fear of stigmatisation by 
health professionals; general state of health of the PLHIV woman; disclosure and non-
disclosure of HIV status to male partner; the HIV status of male partners and the fear of being 
raped.   
                              
5.2. RECOMMENDATIONS  
 There is a need to for more integrated approach to the PMTCT programme by the HIV 
programme managers and PHC nurses. There seem to be too much focus on initiating more 
women on ARVS without paying too much attention to contraception as major factor for 
PMTCT. Focused counselling on family planning must go simultaneously with ARVs 
initiation counselling in the hospital and all the PHC.   
 There is a need to revitalise the campaign to popularise dual protection as a method of choice 
for sexually active PLHIV women in these area. The attitude of the women to health 
professional counselling is still poor. Health professionals need change their attitude and 
approach to counselling from being dictatorial and imposing, to being more explanatory, 
educative and persuasive.   
 There is a need to empower the women economically and the idea being mulled in certain 
quarters that the disability and child support grants given by the 
Department of Social development to be replaced by a substantial basic income grant to all 
PLHIV people needs to be reconsidered.    
 
 
 
 
 
 
 
Stellenbosch University  http://scholar.sun.ac.za
 REFERENCES   
 
1. Adair, T. (2007). Desire for Children and Unmet Need for Contraception among HIV-
Positive Women in Lesotho. Page 3-20. Accessed 14/05/2011 from 
http://www.measuredhs.com/pubs/pdf/WP32/WP32.pdf.      
 
2. Alan E, Greenberg D., Peter, D., James C. (2008). The Epidemiology and Prevention of HIV 
and AIDS. Wallace/Maxcy-Rosenau-Last Public Health and Preventive Medicine. 15
th
 
Edition by Robert Wallace et al. McGraw-Hill, USA. Chapter 11. Page 194-196. 
 
3. Alfonsi, G.A., Shlay, J. (2005). The effectiveness of condoms for the prevention of sexually 
transmitted diseases. Current Women Health Reviews. 2005; 1:151-9.   
 
4. Allen, S., Serufilira, A., Gruber, V., Kegeles, S. & Van de Perre, P., et al. (1993) Pregnancy 
and contraception use among urban Rwandan women after HIV testing and counselling. 
American Journal Public Health 83: 705–710.    
 
5. Avert (2011). HIV and AIDS in South Africa. Accessed on 12/06/2011 from   
    http://www.avert.org/aidssouthafrica.htm.   
 
6. Avert (2011). South Africa HIV & AIDS Statistics. Accessed on 12/06/2011 from http:// 
www.avert.org/safricastats.htm.   
 
7. Bongaarts, J., Westoff, C.F. (2000). The potential role of contraception in reducing 
              abortion. Family Planning Studies 2000; 31:193–202. 
 
8. Barker, PM., Venter, F. (2007). Setting district-based annual targets for HAART and PMTCT 
- a first step in planning effective intervention for the HIV/AIDS epidemic. South African 
Medical Journal 97: 916–917     
 
9. CDC. (2011). Fact sheet on Latex Condom Effectiveness in the prevention of STDs. 
Accessed on 14/06/2011 from http:// www.cdc.gov/condomeffectiveness/latex.htm.  
 
Stellenbosch University  http://scholar.sun.ac.za
10. Christensen, L.B. (2004).  Quantitative Research Method. Experimental Methodology (7th 
Ed.). Boston: USA: Pearson. Page 33-34                                                                               
 
11. Chu, J., Gange, S.J., Anastos, K., et al (2005). Hormonal contraceptive use and the 
effectiveness of highly active antiretroviral therapy. American Journal of Epidemiology 2005; 
161(9):881-90.                                                                                
 
12. Cooper, D., Bracken, H., Myer, L., Zweigenthal, V., Harries, J., Orner, P., Manjezi N, 
Ngubane, P. (2005). Policy Brief: Reproductive intentions and choices Amongst HIV- 
infected individuals in Cape Town, South Africa. Lessons for Reproductive policy and 
service provision from a qualitative study. Policy Brief. Cape Town: Women’s Health 
Research Unit: University of Cape Town, and Population Council.      
 
13. Cooper, D. Harries J., Myer L., Orner P., Bracken H., & Zweigenthal V. (2007). 
             "Life is still going on": Reproductive intentions among HIV-positive women and  
              men in South Africa. Social Science and Medicine, 65 (2): 274-283   
 
14. Delvaux, T., & Nostlinger, C. (2007) Reproductive Choice for Women and Men Living with 
HIV: Contraception, Abortion and Fertility. Reproductive Health Matters, 15(29): 46–66. 
Accessed on 15/05/2011 from 
http://www.who.int/entity/reproductivehealth/publications/rtis/contraception.pdf.  
 
15. Desgrees-Du-Lou, A., Msellati, P., Viho, I., Yao A., Yapi, D., et al. (2002) Contraceptive 
use, protected sexual intercourse and incidence of pregnancies among African HIV-infected 
women. DITRAME ANRS 049 Project, Abidjan 1995–2000. International Journal of 
STD&AIDS 13: 462–468    
 
16. De Cock, K.M., Fowler M.G., Mercier E., I. De Vincenzi, J. Saba, R. Hoff, D.J. Alnwick, M. 
Rogers & Shaffer, N. (2000). Prevention of mother-to-child HIV transmission in resource 
poor countries: Translating research into policy and practice. Journal of the American 
Medical Association 283(9): 1175-1182 
 
17. De Vincenzi, I., Jadand, C., Couturier E., et al. Pregnancy and contraception in a French 
cohort of HIV-infected women. AIDS 1997; 11:333–8.   
Stellenbosch University  http://scholar.sun.ac.za
 18. Dickinson, B.D., Altman, R.D., Nielsen, N., et al. (2001). Drug interactions between oral 
contraceptives and antibiotics. Obstetrics & Gynaecology 2001; 98:853–60.   
 
19. Department of Health of South Africa, Medical Research Council and Macro  
       International (1998). South Africa Demographic and Health Survey, 1998. Pretoria:    
       Department of Health, 2001.   
 
20. DoH (1999).National Framework and Guidelines for Contraceptive Services, Second Draft, 
Pretoria: Department of Health, 1999.   
 
21. DoH (2010) 'National Antenatal Sentinel HIV and Syphilis Prevalence Survey in South 
Africa, 2009' . Accessed on 16/05/2011 from http://www.doh.gov.za/docs/reports/   
 
22. DoH (2010). The South African Antiretroviral Treatment Guidelines. Accessed on 
14/05/2011 from http://www.doh.gov.za/docs/factsheets/guidelines/art.pdf.    
 
23. DSDSA (2011). Grant for caring for a child (Child Support Grant). Accessed on 16/06/2011 
from http://www.capegateway.gov.za/eng/directories/services/11586/47468   
 
24. Farlane, L. (2010). Reproductive Aspirations and Intentions of young women living with 
HIV, in two South African Townships. Accessed on 14/05/2011 from 
http://researchspace.ukzn.ac.za/xmlui/bitstream/handle/10413/377/Lindiwe%20Farlane%202
06521628.pdf?sequence=1.   
 
25. Gazmararian JA, Parker RM, Baker DW. Reading skills and family planning knowledge and 
practices in a low-income managed-care population. Obstetrics &Gynaecology 1999; 
93:239–44.  
 
26. Hankins, C., Tran T., Lapointe, N., et al. (1998) Sexual behaviour and pregnancy outcome in 
HIV-infected women. Journal of AIDS & Human Reproduction 1998; 18:479–87. 
 
27. Harries, J., Cooper, D., Myer, L., Bracken, H., Zweigenthal, V., & Orner P. (2007) Policy 
maker and health care provider perspectives on reproductive decision making amongst HIV-
Stellenbosch University  http://scholar.sun.ac.za
infected individuals in South Africa. Biomed Central Public Health 7-282.  
28. Hassim, S. (2005) “Gender, Welfare and the Development State in South Africa” 
Working Paper Prepared for the UNRISD Project on Gender and Social Policy.  
  
29. HSRC (2008). South African National HIV Prevalence, HIV Incidence, Behaviour and 
Communication Survey, 2008'. Accessed on 12/06/2011 from 
http://www.hsrc.ac.za/SAHA.phtml.         
                                                                    
30. Imbuiki K., Todd, C.S., Stibich, M.A., Schaffer, D.N. & Sinei, S.K. (2010).  Factors 
Influencing Contraceptive Choice and Discontinuation among HIV-Positive Women in 
Kericho, Kenya. African Journal of Reproductive Health December 2010; 14(4):1 05 
Accessed 12/06/2011 from http://www.bioline.org.br/pdf?rh10070  
 
31. Kaida, A., Janssen, P., et al (2010). Contraceptive Use and Method Preference among   
Women in Soweto, South Africa: The Influence of Expanding Access to HIV Care   
and Treatment Services. Accessed on 16/05/2011 from 
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0013868.  
 
32. Laher, F., Todd, C.S., Stibich, M.A., Phofa, R., Behane, X., et al. (2009) A qualitative 
assessment of decisions affecting contraceptive utilization and fertility intentions among 
HIV-positive women in Soweto, South Africa. Journal of AIDS and Behaviour 13: 
Supplement 147–54  
 
33. Land, D.L. et al. (2007). Correlates of inconsistent condom use among Xhosa speaking 
women in South Africa. Accessed on 16/05/2011 from 
http://www.iasociety.org/Default.aspx?pageId=11&abstractId=200714922.     
 
34. London, L., Orner, P.J., & Myer, L. (2008). „Even if you‟re positive you still have rights 
because you are a person.‟ Human rights and Reproductive choice of HIV-positive persons. 
Developing World Bioethics, 8(1): 11–22.   
Magalhaes, J., Amaral, E., Giraldo, P.C., et al. HIV Infection in women: impact on 
contraception. Contraception 2002; 66  
 
Stellenbosch University  http://scholar.sun.ac.za
35. Makiwane, M., Desmond, C. et al. (2006). Is the Child Support Grant associated with an 
increase in teenage fertility in South Africa? Accessed on 16/05/2011 from 
http://www.hsrc.ac.za/module-KTree.doc_request-docid-1337.phtml.   
 
36. McCann, M. (2005) Annexure 3: District Profile   Eastern Cape Chris Hani District 
Municipality (DC13).  Programme of Support to Local Economic Development in the 
Eastern Cape.  Accessed on 10/04/2011 from  
http://www.thinasinako.co.za/files/documents/290806175705.pdf.   
 
37. Mitchell, H.S. & Stephens, E. (2004). Contraception choice for HIV positive women. Sex 
Transmitted Infection 2004; 80:167–173. Doi: 10.1136/sti.2003.008441. Accessed on 
14/05/2011 from www.ncbi.nlm.nih.gov/pmc/articles/PMC1744846/pdf/v080p00167.pdf.  
 
38. Mokoma, T.P., (2008). An analysis of the impact of CSG on teenage fertility rate in South 
Africa.  Accessed on 16/06/2011 from 
http://www.scholar.sun.ac.za/bitstream/handle/10019.1/3325/Mokoma,%20TP.pdf?sequence
=1.  
 
39. Morronni, C., Myer, L., and Tibazarwa, K., (2006). Combined condom and contraceptive use 
among South African Women. Accessed onn16/05/2011 from 
http://www.samj.org.za/index.php/samj/article/viewFile/1172/612.   
 
40. Myer, L., Morronni, C., et al (2002). Dual Method Use in South Africa. 
      International Family Planning Perspectives, 2002, 28(2):119-121. Accessed on   
      16/05/2011 from http://www.guttmacher.org/pubs/journals/2811902.html.    
 
41. Panday, S., Makiwane, M., Ranchod, C., & Letsoalo, T. (2009). Teenage pregnancy in South 
Africa - with a specific focus on school-going learners. Child, Youth, Family and Social 
Development, Human Sciences Research Council. Pretoria: Department of Basic Education. 
Accessed on 16/06/2011 from 
http://www.education.gov.za/LinkClick.aspx?fileticket=uIqj%2BsyyccM%3D&tabid=422&
mid=1300.   
 
Stellenbosch University  http://scholar.sun.ac.za
42. Peltzer, K., Chao, L., & Dana, P. (2008). Family Planning Among HIV Positive and Negative 
Prevention of Mother to Child Transmission (PMTCT) Clients in a Resource Poor Setting in 
South Africa. Journal of AIDS and Behaviour, 20:31-38. 
 
43. Petruney, T., Robinson, E., Reynolds, H., Wilcher, R. & Cates, W. (2008) Contraception is 
the best kept secret for prevention of mother-to-child HIV transmission. World Health 
Organisation Bulletin 86: B  
 
44. Phaweni, K. (2010). Factors Influencing pregnancy desires among HIV positive women in 
Gert Sibande District in Mpumalanga. Gender and Behaviour Publication.  
        Accessed on 16/05/2011 from                                                                             
      http://www.faqs.org/periodicals/201012/2187713201.html#ixzz1MsoWqkMG.  
                                                                                             
45.  Playle, J.F. (2000) Concepts of compliance: understandings and approaches. British Journal 
Family Planning 2000; 26:213–19. 
 
46. PPASA. (2003). “Teen Parental Programme: A baseline survey and needs assessment   
       of adolescents and teen parents in South Africa”, final report.  
 
47. Rehle, T., Shisana, O., Pillay, V., Zuma, K., Puren, A., et al. (2007) National HIV incidence 
measures–new insights into the South African epidemic. South African Medical Journal  97: 
194–199   
 
48. Reynolds, H.W., Janowitz, B., Homan, R., Johnson L (2006). The value of contraception to 
prevent perinatal HIV transmission. Sex Transm Dis 33: 350–356   
 
49. Reynolds, H.W., Janowitz, B. & Cates, W. (2005). Contraception to prevent HIV-positive 
births: Current contributions and potential cost savings in PEPFAR Countries. Sex 
Transmitted Infection. 2005(Supplement II): ii 49-53  
 
50. Siegel K, Schrimshaw EW (2001). Reasons and justifications for considering pregnancy 
among women living with HIV/AIDS. Psychology of Women Quarterly 2001; 25(2):112–23  
 
Stellenbosch University  http://scholar.sun.ac.za
51. Stanwood, N.L, Cohn, S.E., Heiser, J.R., & Pugliese, M. (2007). Contraception and fertility 
plans in a cohort of HIV-positive women in care. Contraception, 75(4): 294 – 298  
 
52. Statistics South Africa (2005). Statistics in brief. Pretoria: Statistics South Africa 
 
53. Stover, J. & Fuchs, N. (2003). Costs and Benefits of adding Family Planning to Services to 
Prevent Mother-To-Child Transmission of HIV. Washington D.C. The Futures.2003   
 
54. Sweat, M.D., O‟Reilly, K.R., Schimid, G.P. et al, 2004. Cost-Effectiveness of Nevirapine to 
Prevent Mother-To-Child HIV Transmission in Eight African Countries. AIDS 2004; 
18:1661-71   
 
55. United Nations (1994). Programme of Action of the United Nations International Conference 
on Population and Development. New York.  
  
56. UNAIDS (2010).  UNAIDS 2010 Report on the global AIDS epidemic. Accessed on 
14/06/2011 from http://www.unaids.org/documents/20101123_GlobalReport_em.pdf.    
 
57. UNAIDS (2008). UNAIDS 2008 report on the global AIDS epidemic‟. Accessed on 
14/06/2011 from 
http://www.unaids.org/en/dataanalysis/epidemiology/2008reportontheglobalaidsepidemic/ 
 
58.  UNAIDS (1999). Sexual behavioural change for HIV: where have the theories taken us? 
Geneva: UNAIDS/99.27E, June 1999 
 
59. UNAIDS (2006). AIDS Epidemic Update. Special report on HIV/AIDS. Geneva UNAIDS, 
December 2006.  
 
60. UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and 
Research Training in Human Reproduction, Department of Reproductive Health and 
Research, & WHO (2002). HIV/AIDS makes dual protection a must. Progress in 
Reproductive Health Research Quarterly Newsletter 2002; No 59  
 
Stellenbosch University  http://scholar.sun.ac.za
61. UNFPA (2004). Clarion Call to Action on Family Planning and HIV/ AIDS in Women and 
children. May 2004 UNFPA Conference. 
 
62. UNGASS (2010). South Africa-2010 UNGASS Country Progress Report. Accessed on 
16/06/2011from: 
http://www.unaids.org/en/dataanalysis/monitoringcountryprogress/2010progressreportssubmi
ttedbycountries/southafrica_2010_country_progress_report_en.pdf.    
 
63. Weller, S. & Davis K (2004). Condom effectiveness in reducing heterosexual HIV 
transmission (Cochrane Review). The Cochrane Library, Issue 2, 2004. Chichester, UK, John 
Wiley & Sons, Ltd   
 
64. WHO (2004). Medical Eligibility Criteria for Contraceptive Use. 3rd ed. Geneva. Accessed 
on 16/06/2011 from http://whqlibdoc.who.int/publications/2004/9241562668.pdf.   
 
65. WHO (2006). Sexual and Reproductive health of Women with HIV: 
 Guidelines on care, treatment and support for women living with HIV and their children in 
resource constrained settings. Accessed on 16/06/2011 from 
http://www.who.int/hiv/pub/guidelines/sexualreproductivehealth.pdf.  
  
66. WHO (2009). Towards Universal Access: scaling up priority HIV/AIDS interventions in the 
health sector: progress report 2009. Geneva: WHO.     
Wilson, T., Massad, L.S., Riester, K.A., et al. Sexual, contraceptive, and drug use behaviours 
of women with HIV and those at high risk for infection: results from the Women‟s 
Interagency HIV Study. AIDS 1999; 13:591–8.       
 
67. Woodsong, C. & Koo, H.P. (1999) Two good reasons: women's and men's perspectives on 
dual contraceptive use, Social Science and Medicine, 1999, 49(5):567-580. 
 
 
 
 
 
 
Stellenbosch University  http://scholar.sun.ac.za
                                                APPENDIX 
 
RESEARCH ETHICS COMMITTEE: HUMAN RESEARCH (HUMANIORA) 
ETHICS COMMITTEE APPLICATION FORM  
 
Application to the University of Stellenbosch RESEARCH ETHICS COMMITTEE: 
HUMAN RESEARCH (HUMANIORA) for clearance of new/revised research projects  
 
This application must be typed or written in capitals 
 
Name: DR. O. K. OLUWOLE 
 
Position/Professional Status: STUDENT/MEDICAL PRACTITIONER 
 
Affiliation: Research Programme/Institution / Department: MPHIL HIV/AIDS 
MANAGEMENT/MANAGEMENT SCIENCES FACULTY/ AFRICAN CENTRE FOR 
HIV AND AIDS MANAGEMENT/ DEPARTMENT OF PSYCHOLOGY 
Please indicate (√) if you are a registered student at SU? 
 
YES √ 
NO  
 
If yes, for which degree/programme are you registered? 
MPHIL HIV/AIDS MANAGEMENT 
 
Please specify the relevant Department at SU: AFRICAN CENTRE FOR HIV/AIDS 
MANAGEMENT   HUMAN PSYCHOLOGY 
  
Who is your supervisor? __DR. THOZAMILE QUBUDA 
 
Telephone and extension no: Code: 047 no. 8748037 
Fax: 0478740115   Code: 047    no. 8740115 
Email: OLUWOLEOLADOTUN404@GMAIL.COM 
Stellenbosch University  http://scholar.sun.ac.za
Title of research project: FACTORS INFLUENCING THE CHOICE OF 
CONTRACEPTIVE METHODS AMONGST HIV POSITIVE WOMEN IN THE 
COFIMVABA AREA 
 
Where will the research be carried out: COFIMVABA HOSPITAL, COFIMVABA. 
 
1. FUNDING OF THE RESEARCH: THE RESEARCH WILL BE FUNDED BY  
            THE RESEARCHER FROM HIS INCOME EARNINGS.   
                                                   
2. PURPOSE OF THE RESEARCH: THE PURPOSE OF THIS STUDY IS TO IDENTIFY 
THE VARIOUS UNDERLYING FACTORS THAT INFLUENCE THE CHOICE OF 
CONTRACEPTIVE METHODS BY PLHIV WOMEN IN THE COFIMVABA 
COMMUNITY AREA 
 
3. AIMS AND OBJECTIVES OF THE RESEARCH:   
1. TO DETERMINE THE KNOWLEDGE, ATTITUDE, PERCEPTION AND PRACTICE OF 
HIV POSITIVE WOMEN  REGARDING CONTRACEPTION METHODS    
2. TO IDENTIFY THE FACTORS THAT INFLUENCE THE CHOICE OF 
CONTRACEPTIVE METHODS   
3. TO IDENTIFY ANY GAPS BETWEEN THEIR KNOWLEDGE AND PRACTICE AS 
DESCRIBED ABOVE  
4. TO IDENTIFY POSSIBLE WAYS IN WHICH THE KNOWLEDGE OF THE HIV 
POSITIVE WOMEN CAN BE ALIGNED WITH THEIR PRACTICAL CHOICE OF 
CONTRACEPTIVE METHODS   
 
SUMMARY OF THE RESEARCH: A QUANTITATIVE RESEARCH APPROACH 
WILL BE ADOPTED FOR THE PURPOSE OF THIS STUDY TO COLLECT SOME 
TYPE OF NUMERICAL DATA IN ORDER TO ANSWER THE RESEARCH QUESTION. 
IT IS A DESCRIPTIVE RESEARCH WHICH AIMS TO ESTABLISH VARIABLES THAT 
EXIST IN A GIVEN SITUATION OR IDENTIFY CAUSAL RELATIONSHIPS. DATA 
WILL BE OBTAINED FROM THE HOSPITAL FILES, MATERNITY CASE RECORDS 
AND RESPONSES OF CONSENTING PARTICIPANTS TO THE QUESTIONNAIRE 
DESIGNED FOR THIS STUDY. THE SURVEY WILL BE CONDUCTED USING A 
QUESTIONNAIRE WHICH CONSISTS OF CERTAIN NUMBER OF CLOSED-ENDED 
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QUESTIONS (ABOUT 25) AND OPENED ENDED QUESTIONS (ABOUT 5). THE 
SAMPLE POPULATION ARE NON-PREGNANT HIV POSITIVE WOMEN CLIENTS 
AGED 16-40 YEARS, ATTENDING COFIMVABA HOSPITAL. THE QUESTIONNAIRE 
WOULD BE PILOTED AND THE FINDINGS PUT INTO CONSIDERATION IN THE 
ADMINISTRATION OF THE QUESTIONNAIRE WHILE CONDUCTING THE 
RESEARCH PROPER. A STRATIFIED SAMPLING METHOD WILL BE USED TO 
SELECT A SAMPLE SIZE OF ABOUT 50 RESPONDENTS BUT ENSURING THERE IS 
AN EVEN DISTRIBUTION OF NUMBERS BETWEEN A SET OF 5-YEAR AGE  
RANGES (16-20, 21-25, 26-30, 31-35, AND 36-40 YEARS). DATA WILL BE 
ANALYSED BY CONVERTING RESPONSES TO NUMERICAL VALUES. THEN THE 
DATA VALUES ARE CAPTURED AND CODED IN EXCEL SPREAD SHEET WHICH 
WILL THEN BE ANALYSED USING STATISTICAL PACKAGE FOR SOCIAL 
SCIENCES. THE RESULTS FROM THE ANALYSIS WILL BE DISCUSSED WITH THE 
AIM TO ACHIEVE THE OBJECTIVES OF THE STUDY. COMPARISONS WITH 
LITERATURE REVIEW AROUND THE RESEARCH QUESTION WILL BE DONE. 
CONCLUSIONS WILL BE MADE AS WELL AS NECESSSARY 
RECOMMENDATIONS WILL BE SUGGESTED.                            
 
5. NATURE AND REQUIREMENTS OF THE RESEARCH 
 
5.1 How should the research be characterized (Please tick ALL appropriate boxes) 
5.1.1 Personal and social information collected directly from participants/subjects            
√ 
5.1.2 Participants/subjects to undergo physical examination 
5.1.3 Participants/subjects to undergo psychometric testing 
5.1.4 Identifiable information to be collected about people from available records                  
√ 
5.1.5 Anonymous information to be collected from available records 
5.1.6 Literature, documents or archival material to be collected on individuals/groups 
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5.2 Participant/Subject Information Sheet attached? (for written and verbal consent) 
 
YES √ 
NO  
  
                                                                              
5.3 Informed Consent form attached? (for written consent) 
 
YES √ 
NO  
 
 
5.3.1. If informed consent is not necessary, please state why: 
 
 
NB: If a questionnaire, interview schedule or observation schedule/framework for 
ethnographic study will be used in the research, it must be attached. The application 
cannot be considered if these documents are not included. 
 
5.4 Will you be using any of the above mentioned measurement instruments in the 
research? 
 
YES √ 
NO  
 
 
6. PARTICIPANTS/SUBJECTS IN THE STUDY 
 
6.1 If humans are being studied, state where they are selected: 
THE PARTICIPANTS WILL BE SELECTED AMONGST NON-PREGNANT HIV 
            POSITIVE WOMEN CLIENTS ATTENDING COFIMVABA HOSPITAL 
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6.2 Please mark (√) the appropriate boxes:  
 
Participants/subjects will: YES NO 
be asked to volunteer √  
be selected √  
 
 
6.2.1 THE PARTCIPANTS WILL BE SELECTED BY STRATIFIED RANDOM  
                        SAMPLING METHOD AND THEN BE ASKED TO VOLUNTEER TO 
                        RESPOND TO THE STUDY QUESTIONNAIRE. 
 
6.2.2.  
Participants/subjects are: YES NO 
Will SU student, alumni of staff data be 
used in this research 
 √ 
Will interviews be conducted with SU 
student, alumni of staff 
 √ 
Will questionnaires be used and 
distributed on SU campuses 
 √ 
Will electronic questionnaires be placed 
on the SU website? 
 √ 
   
6.3 Are the participants/subjects subordinate to the person doing the recruiting? 
 
YES  
NO √ 
 
6.3.1 If yes, justify the selection of subordinate participants / subjects: 
___________________________________________________________________________
_______________________________________________________________ 
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6.4 Will control participants/subjects be used? 
 
YES  
NO √ 
 
 
6.4.1 If yes, explain how they will be selected: 
___________________________________________________________________________
______________________________________________________________   
 
6.5 FORMAL PERMISSION WILL BE OBTAINED FROM PARTCIPANTS OR  
            THEIR LEGAL RESPRESENTATITIVES TO USE RECORDS FROM  
            PARTICIPANTS‟ HOSPITAL FILES, CLINIC CARDS AND MATERNITY CASE  
            RECORD BOOKS.               
 
 
6.6 What is the age range of the participants/subjects in the study? 16-40 YEARS  
                                                                                 
6.6.1 Was consent from guardians/parents obtained for participants/subjects 
  
17 years and younger? 
 
YES √ 
NO  
 
 Appropriate form named “Informed Consent Form 2” is hereby attached. 
 
6.6.2 If NO, please state why: 
___________________________________________________________________________
___________________________________________________________________________
________________________________  
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6.7 Will participation or non-participation disadvantage the participants/subjects in any 
way?     
YES  
NO √ 
                                                                                                                                                                                                                                          
 
6.7.1 If yes, explain in what way: 
___________________________________________________________________________
___________________________________________________________________________
____________________________________________________________ 
 
6.8 Will the research benefit the participants/subjects in any direct way? 
YES √ 
NO  
 
 
6.8.1 If yes, please explain in what way: 
PARTCIPANTS MAY GET THE OPPORTUNITY OF BEING COUNSELLED ON 
HEALTHY CHOICE OF CONTRACEPTIVE METHODS WHICH COULD BE SUITED 
TO THEIR OVERALL WELL BEING AND IMPROVE THE WAY THEY MANAGE 
THEIR REPRODUCTIVE LIFE IN GOOD TANDEM WITH THEIR HIV POSITIVE 
STATUS.   
 
7. PROCEDURES 
 
 7.1 Mark research procedure(s) that will be used: 
Literature  
Documentary  
Personal records √ 
Interviews  
Survey √ 
Participant observation  
Other (please specify)  
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____________________________ 
____________________________ 
 
 
7.2 How will the data be stored to keep it safe and prevent unauthorized access? What 
happens to the data on completion of the research? 
THE RESEARCHER INTENDS TO KEEP A SPECIAL SAFE BOX FOR THE DATA 
COLLECTED AND IN WHICH HE IS THE ONLY ONE WHO HAVE ACCESS TO IT. 
THE DATA WILL BE KEPT SAFE EVEN AFTER COMPLETION OF THE RESEARCH  
IN CASE VERIFICATION MAY BE REQUIRED BY THE UNVERSITY IN THE NEAR 
FUTURE.  
 
7.3 If an interview form/schedule; questionnaire or observation schedule/framework 
will be used, is it attached? 
YES √ 
NO  
 
7.4 Risks of the procedure(s): Participants/subjects will/may suffer:  
 
 
                                                                          
7.4.1 If you have checked any of the above except “no risk”, please provide details:  
THE DISCOMFORT WILL BE ADDRESSED BY REASSURING PARTICIPANTS THAT 
TH ESSENCE OF THE STUDY IS NOT TO BE JUDGEMENTAL BUT TO BRING OUT 
ISSUES THAT COULD BE USED AS VALUABLE INFORMATION TO HELP 
PARTICIPANTS AND OTHER PEOPLE IN SIMILAR SITUATION.  
 
No risk  
Discomfort √ 
Pain  
Possible complications  
Persecution  
Stigmatization  
Negative labeling  
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         8. RESEARCH PERIOD 
 
(a) When will the research commence: AS SOON AS ETHICAL CLEARANCE IS 
OBTAINED FROM THE UNIVERSITY RESEARCH ETHICS COMMITTEE 
(b) Over what approximate time period will the research be conducted: TWO TO THREE 
WEEKS  
 
9. GENERAL 
 
 9.1 Has permission of relevant authority been obtained? 
 
YES √ 
NO  
              (PERMISSION LETTER ATTACHED TO APPLICATION) 
9.1.1 If yes, state name of authority: 
              THE MANAGEMENT OF COFIMVABA HOSPITAL, COFIMVABA 
 
9.2 Confidentiality: How will confidentiality be maintained to ensure that 
participants/subjects/patients/controls are not identifiable to persons not involved in the 
research: .THE NAMES OF PARTICIPANTS WILL NEITHER BE WRITTEN ON THE 
QUESTIONNAIRES NOR THE CONSENT FORM IN ORDER TO MAINTAIN 
ANONYMITY OF THE PARTICIPANTS. INSTEAD, EACH PARTICIPANT WILL BE 
ALLOTTED STUDY IDENTIFICATION NUMBER. DATA COLLECTED WILL BE 
KEPT SECRET AND SAFE ALL THE TIME. 
 
9.3 Results: To whom will results be made available, and how will the findings be 
reported to the research participants? THE RESULTS WILL BE MADE AVAILABLE 
TO THE AFRICAN CENTRE FOR HIV/AIDS MANGEMENTS. THE RESEARCH 
PARTICIPANTS WILL BE ASKED TO CHECK FOR THE FINDINGS OF THE STUDY 
AT THE ANTIRETROVIRAL UNIT OF THE HOSPITAL FROM APRIL 2012   
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9.4 There will be financial costs to: 
 
participant/subject  
institution  
Other (please specify) 
researcher_______________________ 
____________________________ 
                            
√ 
 
9.4.1 Explain any box marked YES: 
THE RESEARCHER WILL BE FUNNDING THE RESEARCH FROM HIS INCOME 
EARNINGS. 
 
 9.5 Research proposal/protocol attached: 
 
YES √ 
NO  
 
9.6 Any other information which may be of value to the Committee should be provided 
here: 
__________________________________________________________________ 
 
05/09/2011                                                
Date:       Applicant`s signature 
 
 
______________________   ________________________ 
 
Who will supervise the project? 
 
Name: DR. THOZAMILE QUBUDA Programme/Institution/Department: -
AFRICAN CENTRE FOR HIV/AIDS MANAGEMENT 
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Date: ____________________ Signature: _____________________ 
 
 
Director/Head/Research Coordinator of Department/Institute in which study is 
conducted: 
 
I declare that this research proposal has been approved by the relevant Department or 
Faculty and that it complies with acceptable scientific research standards.  
 
Name: _______________________ 
     
Date: _________________ Signature: _____________________    
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                                 STELLENBOSCH UNIVERSITY 
CONSENT TO PARTICIPATE IN RESEARCH 
  
 
Title: Factors Influencing Choice of Contraceptive Methods amongst HIV Positive 
Women in the Cofimvaba Area    
You are asked to participate in a research study conducted by Dr. O.K Oluwole, M.B.CH.B 
(Ile-Ife) PDM (Stellenbosch), from the African Centre for HIV/AIDS Management at 
Stellenbosch University. The results of the study will be contributed to a research thesis for 
the Award of a Masters of Philosophy Degree in HIV/AIDS Management.  You were 
selected as a possible participant in this study because you fall into the study population and 
could provide valuable information that may contribute to the achievement of the purpose 
and significance of the study. 
1. PURPOSE OF THE STUDY  
The aim of this study is to identify the various underlying factors that influence the choice of 
contraceptive methods by PLHIV women in the Cofimvaba community area.  
 
2. PROCEDURES  
You will be required to respond to a questionnaire which consists of certain number of 
closed-ended questions (about 35) and opened ended questions (about 5) written in English 
language. The questionnaire will be self-administered or via interpretation by a delegated 
trustworthy Xhosa-speaking nurse. It may take 30minutes of your time to complete the 
questionnaire. Your bio data may also be obtained from your hospital folder records, clinic 
card and (or) maternity case record where necessary. 
 
3. POTENTIAL RISKS AND DISCOMFORTS  
The risks for this study are minimal except that it may cause discomfort by provoking some 
emotional or psychological reaction depending on whether you have accepted your HIV 
Stellenbosch University  http://scholar.sun.ac.za
positive status or if the circumstances to be blamed for your status are related to any 
questions being asked in the questionnaire. We will like to deal with this minor discomfort by 
reassuring you that the essence of the study is not to be judgemental. Neither is it an attempt 
to probe unnecessarily into your privacy but to bring out issues that could be used as valuable 
information to help participants and other people in similar situation. We have put everything 
in place to ensure that such information is kept strictly confidential and only for the purpose 
of this study. You are welcomed to seek further counselling with the researcher if you 
encounter any discomfort.                                          
 
4. POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY 
The potential benefits of this study to you are that it may help you to adopt a better approach 
to the planning of your reproductive life and also help you make healthier choices in the 
management of your HIV condition. The benefits of this study to the society is that it may 
help in better approach to HIV prevention and family planning services by healthcare 
practitioners and HIV/AIDS programme managers, reduce the risk of HIV positive women 
getting re-infected with more viral load, reduce the risk of HIV positive women infecting to 
both knowing and unknowing sero-discordant sexual partners, and in the long term reduce the 
incidence and prevalence of HIV in this area  
 
5. PAYMENT FOR PARTICIPATION  
Participation in this study is voluntary. No payment will be made for participation in the 
study but refreshments may be provided for the inconveniences.  
 
6. CONFIDENTIALITY 
Any information that is obtained in connection with this study and that can be identified with 
you will remain confidential and will be disclosed only with your permission or as required 
by law. Confidentiality will be maintained in this way: The names of participants will neither 
be written on the questionnaires nor the consent to maintain anonymity of the participants. 
Instead, each participant will be allotted study identification number. Data collected will be 
kept secret and safe all the time with the researcher. The information might also be inspected 
by the University of Stellenbosch, Human Research Ethics Committee. The records will only 
be utilized by them in carrying out their obligations relating to this study. 
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7. PARTICIPATION AND WITHDRAWAL 
You can choose whether to be in this study or not.  If you volunteer to be in this study, you 
may withdraw at any time without consequences of any kind.  You may also refuse to answer 
any questions you don‟t want to answer and still remain in the study. The investigator may 
withdraw you from this research if circumstances arise which warrant doing so.   
 
8. IDENTIFICATION OF INVESTIGATORS 
If you have any questions or concerns about the research, please feel free to contact: The 
researcher, Dr. O.K. Oluwole at Cofimvaba Hospital on 0835247047 OR my supervisor Dr. 
Thozi Qubuda at African Centre for HIV/AIDS Management on 021-8083002.  
 
9. RIGHTS OF RESEARCH SUBJECTS 
You may withdraw your consent at any time and discontinue participation without penalty.  
You are not waiving any legal claims, rights or remedies because of your participation in this 
research study.  If you have questions regarding your rights as a research subject, contact Ms 
Maléne Fouché [mfouche@sun.ac.za; 021 808 4622] at the Division for Research 
Development.   
                                                                                 
 
SIGNATURE OF RESEARCH SUBJECT  
 
The information above was described to me                                       by Oladotun Oluwole in 
English and I am in command of this language or it was satisfactorily translated to me in 
Xhosa Language by                                    . I was given the opportunity to ask questions and 
these questions were answered to my satisfaction.  
 
I hereby consent voluntarily in this study. I have been given a copy of this form. 
 
Initials of Subject/Participant 
 
________________________________________   ______________ 
Signature of Subject/Participant                                                         Date 
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 SIGNATURE OF INVESTIGATOR  
 
I declare that I explained the information given in this document to __________________ 
and/or her representative ____________________. She was encouraged and given ample 
time to ask me any questions. This conversation was conducted in English and no translator 
was used or this conversation was translated into Xhosa by _______________________. 
 
_____ ___________________________________  ______________     
Signature of Researcher                  Date   
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                                   STELLENBOSCH UNIVERSITY   
  
CONSENT TO PARTICIPATE IN RESEARCH (FOR LEGAL 
REPRESENTATIVE) 
Title: Factors Influencing Choice of Contraceptive Methods amongst HIV Positive 
Women in the Cofimvaba Area    
Your daughter/ward is being asked to participate in a research study conducted by Dr. O.K 
Oluwole, M.B.CH.B (Ile-Ife) PDM (Stellenbosch), from the African Centre for HIV/AIDS 
Management at Stellenbosch University. The results of the study will be contributed to a 
research thesis for the Award of a Masters of Philosophy Degree in HIV/AIDS Management.  
She was selected as a possible participant in this study because she falls into the study 
population and could provide valuable information that may contribute to the achievement of 
the purpose and significance of the study.  
 
1. PURPOSE OF THE STUDY  
The aim of this study is to identify the various underlying factors that influence the choice of 
contraceptive methods by PLHIV women in the Cofimvaba area.  
 
2. PROCEDURES  
Your daughter or ward will be required to respond to a questionnaire which consists of 
certain number of closed-ended questions (about 35) and opened ended questions (about 5) 
written in English language. The questionnaire will be self-administered or via interpretation 
by a delegated trustworthy Xhosa-speaking nurse. It may take 30 minutes of her time to 
complete the questionnaire. Her bio data may also be obtained from her hospital folder 
records, clinic card and (or) maternity case record where necessary. 
 
3. POTENTIAL RISKS AND DISCOMFORTS  
The risks for this study are minimal except that it may cause discomfort by provoking some 
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emotional or psychological reaction depending on whether you have accepted your HIV 
positive status or if the circumstances to be blamed for your status are related to any 
questions being asked in the questionnaire. We will like to deal with this minor discomfort by 
reassuring you that the essence of the study is not to be judgemental. Neither is it an attempt 
to probe unnecessarily into your privacy but to bring out issues that could be used as valuable 
information to help participants and other people in similar situation. We have put everything 
in place to ensure that such information is kept strictly confidential and only for the purpose 
of this study. You are welcome to seek further counselling with the researcher if you 
encounter any discomfort.                              
 
4. POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY 
The potential benefits of this study to your daughter/ward are that it may help her to plan her 
reproductive life better and also help her to address her overall health better. The benefits of 
the study to the society is that it will help in better approach to HIV prevention and family 
planning services, reduce the risk of HIV positive women getting re-infected with more viral 
load, reduce the risk of HIV positive women infecting to both knowing and unknowing sero-
discordant sexual partners, and reduce the risk of vertical transmission of HIV to children, 
reduce infant mortality rates from HIV/AIDS, and in the long term reduce the incidence and 
prevalence of HIV in this area  
 
5. PAYMENT FOR PARTICIPATION  
Participation in this study is voluntary. No payment will be made for participation in the 
study but refreshments may be provided for the inconveniences.  
 
6. CONFIDENTIALITY 
Any information that is obtained in connection with this study and that can be identified with 
your daughter/ward will remain confidential and will be disclosed only with your permission 
or as required by law. Confidentiality will be maintained in this way: The names of 
participants will neither be written on the questionnaires nor the consent to maintain 
anonymity of the participants. Instead, each participant will be allotted study identification 
number. Data collected will be kept secret and safe all the time with the researcher.  
The information might also be inspected by the University of Stellenbosch, Human Research 
Ethics Committee. The records will only be utilized by them in carrying out their obligations 
relating to this study.  
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7. PARTICIPATION AND WITHDRAWAL 
You can choose whether your daughter/ward should be in this study or not.  If you volunteer 
her to be in this study, you may withdraw her at any time without consequences of any kind.  
She may also refuse to answer any questions she does not want to answer and still remain in 
the study. The investigator may withdraw your daughter/ward from this research if 
circumstances arise which warrant doing so.   
 
8. IDENTIFICATION OF INVESTIGATORS 
If you have any questions or concerns about the research, please feel free to contact: The 
researcher, Dr. O.K. Oluwole at Cofimvaba Hospital on 0835247047 OR my supervisor Dr. 
Thozi Qubuda at African Centre for HIV/AIDS Management on 021-8083002.  
 
9. RIGHTS OF RESEARCH SUBJECTS 
You may withdraw your consent at any time and discontinue your ward‟s/daughter‟s 
participation without penalty.  You are not waiving any legal claims, rights or remedies 
because of your ward or daughter‟s participation in this research study.                                                     
If you have questions regarding your rights as a research subject, contact Ms. Maléne Fouché 
[mfouche@sun.ac.za; 021 808 4622] at the Division for Research Development. 
 
SIGNATURE OF RESEARCH SUBJECT’S LEGAL REPRESENTATIVE  
 
The information above was described to my daughter/ward and me                                       by 
Oladotun Oluwole in English and I am in command of this language or it was satisfactorily 
translated to me in Xhosa Language by                                   . I and my daughter/ward were 
given the opportunity to ask questions and these questions were answered to our satisfaction.  
 
I hereby consent voluntarily that my daughter/ward (name of 
participant)______________________ may participate in this study. I have been given a 
copy of this form.  
 
 
________________________________________ 
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Name of legal representative 
 
 
________________________________________   ______________ 
Signature of Legal representative                                                       Date 
 
 
SIGNATURE OF INVESTIGATOR  
 
I declare that I explained the information given in this document to __________________ 
and her representative ____________________.They were encouraged and given ample time 
to ask me any questions. This conversation was conducted in English and no translator was 
used or this conversation was translated into Xhosa by _______________________. 
 
 
 
________________________________________  ______________  
Signature of Researcher      Date  
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RESEARCH TITLE: FACTORS INFLUENCING THE CHOICE OF CONTRACEPTIVE  
                                      METHODS AMONGST HIV POSITIVE WOMEN IN THE   
                                                        COFIMVABA AREA   
RESEARCHER: DR. O.K OLUWOLE           STUDENT NUMBER: 15933598 
________________________________________________________________________      
INSTRUCTIONS: Thank you for taking your time to consent and participate in the response 
to the questionnaire of this study. The questionnaire may take you about 30 minutes to 
complete. This questionnaire has four sections. The first section asks for your Bio data and 
General Information while the last three sections test your knowledge, attitude or perception 
and behaviour on choice of contraceptive methods. Majority of the questionnaires are closed 
ended questions where your responses are either Yes. No and Don‟t Know. Mark X or √ in 
the boxes provided. You are expected to make your response to the open ended questions as 
simple as possible. Ask for any explanation from the researcher or the delegated interpreter 
on any of the questions.   
 
SECTION A                  BIODATA AND GENERAL INFORMATION 
(1) Age: 
 
(2)Marital status:                  
Never married  
Married  
Divorced/Separated  
Widowed  
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  (3)Employment status:                                                                 
 
  
     
(4)If unemployed, what is your financial means of living? 
__________________________________________________
_________________________   
(5)Average house hold monthly income      
<R500  
R501-R1000  
R1001-R1500  
R1501-R2000  
>R2000  
           
(6)Number of sexual partners in the last 1 year: ____________________________________ 
(7) Are you using ARVs or HAART currently?   
Yes  
No  
(8)Parity   
    a. Number of Living Children: _____________  
    b. Number of Dead Children: ______________ 
      
 
 
 
 
 
 
 
 
 
 
Employed  
Unemployed  
Never Worked  
Schooling  
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SECTION B                      TEST OF KNOWLEDGE 
1. In what ways is HIV transmitted? 
 Yes No Don‟t know 
(a)Unprotected sex with infected person    
(b)Transfusion with infected blood    
(c)Pregnant mother to unborn child    
(d) Sharing sharp objects with infected person    
(e)Kissing infected person     
(f)Hugging or touching infected person        
(g)Using the same toilet with infected person    
  
2. How can HIV infection or transmission be prevented? 
 Yes No Don‟t Know 
(a)Abstinence from sex    
(b)Using condoms always    
(c)Using condom sometimes    
(d)Using oral contraceptive pills    
(e)Using family planning injection    
f)Being faithful to one sexual partner    
(g)Use of ARV‟s by pregnant mothers    
 
3. Mention every contraceptive or family planning methods that you know or aware of: 
___________________________________________________________________________
_______________________________________________________________  
 
4. Which family planning methods can prevent pregnancy, HIV infection and other Sexually 
Transmitted Infections? _________________________________  
 
 
5. Which of the following is the preferred family planning method for sexually active HIV 
positive women?   
 Yes No Don‟t Know 
(a)Using condoms only     
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(b)Using family planning injection only    
(c)Using IUCD‟s or loops only    
(d)Using family planning pills only    
 (e) Tying or Cutting the fallopian tubes by 
surgical operation    
   
(f)Using Skin Implants only                                     
 
 
g)Using condoms in combination with   
any other above 
   
 
6. Do you know that an HIV positive women health condition could get worse if she continues 
having unprotected sex with an infected partner?  
Yes No Don‟t Know 
   
       
7. Do you know that early beginning of the use ARVs and good compliance with the 
medications may greatly reduce the risk of a pregnant mother from infecting her unborn 
baby?                                                                      
Yes No Don‟t Know 
   
  
8. Have you ever been counselled by health professionals on dual protection   
(Condom combined with another method) as a method of choice for contraception for HIV 
positive women?   
Yes No Don‟t Know 
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9. Which of the following factors do you know may influence or affect the choice of 
contraceptive method by HIV positive women?    
 Yes No Don‟t Know 
(a)Pregnancy desires or intentions?    
(b)Counselling by health professionals?    
(c)General states of health (feels sick or feel healthy?    
(d)Family, social and (or) cultural pressure    
(e) Pressure from male partner?    
(f)Disclosure or non-disclosure of HIV status  
     to partner? 
   
(g) HIV status of partner (positive or negative?)    
(h) Use or  non-use of  HAART or ARV‟s pills    
(j)Fear of stigmatisation by health professionals?    
 (i) Fear of stigmatisation by family or friends?    
(k)Side effects of the contraceptives method    
 (l) Being employed or unemployed?    
(m)Financial needs for child support grant?    
(n)Access to or availability of the contraceptives 
methods at your nearest clinic /health centre? 
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SECTION C          TEST OF ATTITUDE AND PERCEPTION  
1.  Looking at the circumstances around you, which contraceptive method(s) do you feel 
is/are suited for you? 
__________________________________________________________ 
2. Do you think or feel that pregnancy desires or intentions may influence your choice of 
contraceptive method?                        
Yes No  Don‟t Know 
   
   
3. Do you think or feel your general state of health (being sick or healthy) could affect your 
choice of contraceptive method?             
 
         
Yes No  Don‟t Know 
   
                                            
4. Do you think or feel that family; social or cultural pressure that a woman must have 
children would affect your choice of contraceptive method?        
Yes No  Don‟t Know 
   
 
 5. Do you think or feel that health workers counselling can influence your choice of 
contraceptive methods?                
Yes No  Don‟t Know 
   
                                  
6. Do you think or feel that health workers attitudes and approach to family planning 
counselling can influence or affect your choice of contraceptive method?           
Yes No  Don‟t Know 
   
                                               
7.  Do you think the type of contraceptive methods available at your nearest clinics or health 
centres affects your choice of contraceptive method?          
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Yes No  Don‟t Know 
   
 
8. Do you think or feel your male partner may influence your choice of contraceptive 
method?      
Yes No  Don‟t Know 
   
 
9. Do you think or feel whether or not disclosing your HIV status to your partner could affect 
your choice of contraceptive method?  
Yes No  Don‟t Know 
   
 
10. Do you think the HIV status of your partner (either positive or negative) will affect your 
choice of contraceptive method?  
Yes No  Don‟t Know 
   
 
11. Do you think the fear of stigmatisation or discrimination by family or friends could affect 
your choice of family planning method? 
Yes No Don‟t Know 
   
 
12. Have you ever perceived anything in health workers attitude during counselling that 
suggest HIV positive women must not bear children?  
Yes No Don‟t Know 
   
 
13. Do you think/ feel the side effects of contraceptive methods could affect your choice of 
family planning methods?  
Yes No  Don‟t Know 
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14. Mention any side effects you have felt with any contraceptive that might have used 
before______________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________ 
15. Do you think or feel the fear of being stigmatised by your partner may affect your 
demand for condom use?                
Yes No  Don‟t Know 
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                                                       SECTION D 
                               TEST OF PRACTICE/BEHAVIOUR 
1. What contraceptive method(s) are you using now? 
__________________________________ 
2. What are the reasons for your choice? _________________________________________  
___________________________________________________________________________  
___________________________________________________________________________ 
3. Do you use the method consistently, or all the time? 
Yes No 
  
 
4. If your response to 3 above is No, please tell us why? 
__________________________________________________________________________  
___________________________________________________________________________ 
5. Have you disclosed your status to your partner? 
Yes No 
  
 
6. Have you made your partner to get tested for HIV?                
Yes No 
  
 
7. Can you insist on condom use by your partner? 
Yes No 
  
  
8. Do you have plans to have more children?                               
Yes No 
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9. If yes is the response to last question, does this affect your choice of contraceptive method?   
Yes No 
  
10.  If yes is the response to question 8, does the benefit of getting a child support grant has 
anything to do with future pregnancy desires?                                                                       
 
11. If the government decides to give tangible money as Basic Income Grant monthly for all 
unemployed people instead of child support grants, will it change your choice of 
contraceptive method?                      
Yes No  Don‟t Know 
   
 
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                    
Yes No 
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                                          TABLES AND CHARTS 
 
 2. Marital Status 
                                                         TABLE A.2 
  
 
  
 
 
 
 
 
 
 
Age Range Never married Married Divorced/SeparatedWidowed Total (n)
16-20 10 0 0 0 10
21-25 10 0 0 0 10
26-30 7 3 2 0 12
31-35 3 5 0 1 9
36-40 6 3 0 0 9
Total 36 11 2 1 50
% 72 22 4 2 100
0
1
2
3
4
5
6
7
8
9
10
FIGURE A.2
16-20
21-25
26-30
31-35
36-40
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       3. Employment Status 
                                                             Table A.3   
  
 
 
 
  
 
 
 
 
         
 
Employed Unemployed Never worked SchoolingTotal (n)
Age Range
16-20 0 4 3 3
21-25 1 6 1 2
26-30 1 10 1 0
31-35 2 6 1 0
36-40 0 7 1 1
Total 4 33 7 6 50
% 8 66 14 12 100
0
1
2
3
4
5
6
7
8
9
10
Figure A.3
Age Range
16-20
21-25
26-30
31-35
36-40
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4. Financial means of living for the unemployed/ never worked/schooling  
                                           
                                       Table A.4  
  
 
  
 
 
 
 
0
5
10
15
20
25
Figure A.4
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                Figure A.5   
  
 
       
 
 
  
No 5. Average household monthly income 
Table A.5
Group Value (n) Score (%)
<R500 26 52
R501-R1000 13 26
R1001-R1500 5 10
R1501-R2000 2 4
>R2000 4 8
Total 50 100
No. 6. Number of Sexual Partner(s) in the alst one yearlast one year
TableA.6
Group Value(n) Score %
None 1 2
One 41 82
Two 8 16
Total 50 100
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7a. Are you Using ARVs Or HAART currently?
Table A.7a
Group Value (n) %
Yes 44 88
No 6 12
Total 50 100
Yes
88%
No
12%
Are you using ARVs or HAART currently?
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7b. Is Nevirapine Contained in respondent HAART Regimen?
Table A.7b
Regimen Value (n) %
Nevirapine-Containing Regimen 27 61
Non-Nevirapine Containing regimen 17 39
Total 44 100
No 8a. Number of Living Children
Figure A.8a
Group Value (n) %
None 6 12
One 22 44
Two 14 28
Three 4 8
Four 3 6
Five 1 2
Total 50 100
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No 8b. Number of dead children
Table A.8b
Group Value (n) %
None 36 72
One 12 24
Two 1 2
Three 1 2
Total 50 100
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                                           SECTION B DATA ANALYSIS 
 
                   
  
In what ways is HIV transmitted?  
Table B.1
Group Yes No Don’t Know %
Unprotected sex with infected person 44 4 2 88
Transfusion with infected blood 35 8 2 70
Pregnant mother to unborn child 28 15 7 56
Sharing sharp infected objects 31 12 7 62
Kissing infected person 2 45 3 90
Hugging or touching infected person 3 45 2 90
Using the same toilet with infect person 3 44 3 90
Average 78
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Yes 
88%
No 
8%
Don‟t 
Know
4%
Unprotected sex with infected person
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No 2.  How can HIV infection be prevented?
Table B.2
Yes (n) No (n) Don'T Know (n) Knowledge Score score (%)
Abstinence from sex 42 6 2 84
Using condom always 49 1 0 98
Using condom sometimes 7 40 3 80
Using oral contraceptives 10 30 10 60
Using family planning injections 11 35 4 70
Being faithful to one sexual partner 35 12 3 70
Use of ARVs by pregnant mothers 33 10 7 66
Average 75.4286
Stellenbosch University  http://scholar.sun.ac.za
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No 3. Mention every contraceptive methods that you know 
Table B.3
Group Value (n) Score(%)
Condom Only 8 16
Condom and Injectable 10 20
Injectables Only 11 22
Condom + Injectable + OCP 7 14
Injectable + OCP 3 6
Loop+ Injectable+ Condom 1 2
Abstinence + Injectable + Condom 3 6
Abstinence + Injectable + Condom +OCP 1 2
Abstinence + Injectables + Condom + OCP + Loop 1 2
Injectable + OCP + Condom + Loop 2 4
Don't know anyone 3 6
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No 4. Which family planning method can prevent pregnancy, HIV and sexually 
transmitted infections?      
                                         
     
                                                                                                 
No 5. Which of the following is the preferred family planning method for sexually active 
HIV positive women? 
                                           Figure B.5 
Know at least about condom = 66%
Know at least about injectables = 76%
Know at least about OCP    =  30%
Know at least about IUCD    = 8%
Table B.4
Group Value (n) %
Condom 40 80
Abstinence 4 8
Injectables 2 4
None 3 6
Don‟t Know 1 2
Total 50 100
Figure B.5
Group Yes (n) No (n) Don’t Know (n)  %
Using Condoms only 35 11 4 22
Using family planning injectables only 10 36 4 72
Using IUCDs or Loops only 5 30 15 60
Using Family planning pills or OCP only 10 35 5 70
Using Skin implants only 6 29 15 58
Using Condoms in plus any other above 37 6 7 74
Average 59.3333
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Stellenbosch University  http://scholar.sun.ac.za
No 6. Do you know that an HIV positive woman health condition could get worse if she 
continues having unprotected sex with an infected partner? 
  
                                       Figure B.6 
             
  
   
 
No 7. Do you know that early beginning of the use of ARVs and good compliance with 
the medications may greatly reduce the risk of a pregnant mother from infecting her 
unborn baby with HIV? 
  
 
                                                  Figure B.7 
Table B.6
Group Value (n) %
Yes 46 92 Knowledge Score= 92%
No 3 6
Don't know 1 2
Total 50 100
Table B.7
Yes No Don‟t know Total
Value (n) 40 6 4 50
% 80 12 8 100
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No 8. Have you ever been counselled by health professionals on dual protection 
(condom combined with another method) as a method of choice for contraception for 
HIV positive women?  
   
 
Knowledge Score (%) = 90% 
 
 
 
 
 
 
 
 
 
 
 
 
Table B.8
Yes No Don‟t Know Total
Value (n) 45 3 2 50
% 90 6 4 100
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                                                     Figure B.8 
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No 9. Which of the following factors do you know may influence or affect the choice of  
          contraceptive methods in HIV positive women?     
                                                      
                                        Table B.9  
Factors Yes No Don’t 
know 
Knowledge 
score (%) 
Pregnancy desires or intentions? 35 7 8 70 
Counselling by health professionals? 42 7 1 84 
General state of health (feeling sick or healthy)? 30 15 5 60 
Family, social or cultural pressures? 34 15 1 68 
Pressure from male partner? 30 18 8 60 
Disclosure or non-disclosure of HIV status to 
partner? 
30 15 5 60 
HIV status of partner (positive or negative)? 30 15 5 60 
Use or non-use of HAART or ARVs Pills? 35 11 4 70 
Fear of stigmatisation or discrimination by family 
or friends? 
28 18 4 56 
Fear of stigmatisation by health professionals? 31 15 4 62 
Side effects of the contraceptive methods? 39 6 5 78 
Being employed or unemployed? 17 30 4 34 
Financial needs for child support grants? 38 10 2 76 
Access to or the availability of the contraceptive 
methods at your nearest clinic? 
37 8 5 74 
   Average 66% 
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                               SECTION C DATA ANALYSIS  
 
1. Looking at the circumstances around you, which contraceptive method do you feel 
is/are best suited for you?  
  
 
  
 
                              Figure C.1 
Table C.1
Group Value (n) %
Condom Only 31 62
Condom and Injectable 3 6
Condom and OCP 1 2
Injectable Only 10 20
OCP Only 1 2
Nothing 2 4
Don‟t Know 3 4
Total 50 100
Positive Perception to use of Dual Protection= 8%
Favourable perception to unprotected sex= 32%
Favourable perception to using condom protection=70%
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No.2. Do you think or feel that pregnancy desires or intentions may influence your 
choice of contraceptive method? 
 
Group Value 
(n) 
% 
Yes 24 48 
No 19 38 
Don‟t 
know 
7 14 
Total 50 100 
 
                   Figure C.2   
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No 3. Do you think or feel your general state of health (being sick or healthy) could 
affect your choice of contraceptive method? 
 
                
 
                 
 
 
 
 
 
 
 
 
 
 
 
  
Figure C.3
Group Value (n) %
Yes 21 42
No 23 46
Dont know             7 14
Total 50 100
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                                                    Figure C.3 
  
 
No 4. Do you think or feel family; social or cultural pressures that a woman must have 
children would affect your choice of contraceptive method?    
           
                                 
 
                                                  Figure C.4 
 
Figure C.4
Group Value (n) %
Yes 20 40
No 25 50
Don‟t know 5 10
Total 50 100
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 No 5. Do you think or feel that health workers counselling can influence your choice of 
contraceptive method?  
                                         
 
                                                Figure C.5 
         
 
No 6. Do you think or feel that health workers attitude and approach to family planning 
counselling can influence or affect your choice of contraceptive methods? 
 
                           
 
 
 
 
  
Table C.5
Group Value (n) %
Yes 18 36
No 27 54
Don‟t know 5 10
Total 50 100
Table C.6
Group Value (n) %
Yes 18 36
No 27 54
Don‟t know 5 10
Total 50 100
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                                           Figure C.6  
 
  
 
No 7. Do you think or feel that the contraceptive methods available at your nearest 
clinic or health centres affect your choice of contraceptive methods? 
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No 8. Do you think or feel your male partner may influence your choice of 
contraceptive method?          
                                            Figure C.8 
  
 
No 9. Do you think or feel whether or not disclosing your status to your partner could 
affect your choice of contraceptive method?  
                                            Figure C.9 
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No 10. Do you think the HIV status of your partner (either positive or negative) will 
affect your of contraceptive method?    
                                                   Figure C.10 
  
 
11. Do you think the fear of stigmatisation or discrimination by family or friends could 
affect your choice of family planning method?     
 
                                              Figure C.11  
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No 12. Have you ever perceived anything in health workers attitude during counselling 
that suggest HIV positive women must not bear children?    
                                                               Figure C.12  
  
 
No 13. Do you think or feel the side effects of contraceptive methods could affect your 
choice of contraceptive method?   
 
                                        Figure C.13   
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No 14. Mention any side-effects you have felt with any contraceptive you might have 
used before? 
                 Table C.14 
                                 
Side effects felt Value 
(n) 
% 
Vaginal discharge 4 7 
Headaches 2 3.6 
Irregular Menses 4 7 
Amenorrhoea 7 12.7 
Weight gain 1 1.8 
Dysmenorrhoea 2 3.6 
Nausea  1 1.8 
Dizziness  1 1.8 
Tiredness  1 1.8 
Backache 1 1.8 
No side effects 32 58.1 
Total  55 100 
 
 
3/4 (75%) of those who felt vaginal discharge are currently not using any contraceptive. 
       
The two feeling headaches are currently using injectables and OCP respectively.  
      
All having irregular menses are currently using injectables.     
   
All having amenorrhoea are currently using injectables.   
*16/32 (50%) of those who felt no side effects are currently using condoms while 2/32 (6.25 
%) are currently using Dual protection. 
     
* = After Cross-checking with Section D 1.  
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                                        Figure C.14   
  
 
No 15. Do you think or feel being stigmatised by your partner may affect your choice of 
contraceptive method?   
                                                     Figure C.15  
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C.16. Average positive response on attitude and Perception to factors influencing choice 
of contraceptive methods  
  Table C.16   
                             
Group Yes 
(%) 
Q2 48 
Q3 42 
Q4 40 
Q5 36 
Q6 36 
Q7 44 
Q8 26 
Q9 42 
Q10 38 
Q11 26 
Q12 32 
Q13 26 
Q15 36 
Average 36.3077 
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      SECTION D DATA ANALYSIS   
 
    
 
 
 
 
                                         Figure D.1  
  
 
 
No 1.What contraceptive method are you using now?
Table D.1`
Group Value (n) %
Condom Only 28 56
Injectable Only 14 28
OCP Only 2 4
IUCD Only 1 2
None at all 3 6
Condom +Injectable 2 4
Total 50 100
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    N.B. one respondent gave 2 different reasons as grouped above  
 
 
 
     
 
  
No 2. Reasons for using present contraceptive method…..
2a. None at all- (3)
Reasons Value (n)
Looking to get pregnant and have baby 2
I don‟t have a boyfriend now 1
Total 3
2b. Oral Contraceptive Pills (OCP) users (2)(OCP) only users
Reason Value (n)
To make my menstruation regular again 1
Simply satisfied and comfortable with the pills 1
Total 2
2c. IUCD user (1) only user (1)
Reasons- no side effect and can stay for 5 years
2d.Injectables + Condom users (2)
Reasons Value (n)
The Condom also prevent STIs 1
The condom prevent infection and pregnancy in case of rape 1
Total 2
2e. Injectables Only Users (14)
Reasons Value (n)
Does not want to loose blood through menses (Prefers Amenorrhoea) 1
The 2-3 months interval makes it convinient and easy to remember 3
Simply satisfied and comfortable with the injections 3
Does not want another baby born with HIV infection 4
It‟s the method available at the nearest clinic 1
Does not want to get pregnant in case of rape 1
Want to gain weight and be more healthy 1
Prevent pregnancy for now and have a baby later 1
Total 15
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                                                       Figure D.2e 
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                                                  Figure D.2f 
  
 
 
 
 
 
Table D.2f
Reasons Value (n) % (/28)
To prevent getting pregnant and having baby born with HIV 15 53
Do not want to infect my partner 8 29
To prevent STIs 12 43
To prevent getting more HIV infection 8 29
No pains 1 3.5
Easy to use 1 3.5
Can decide to have a baby later 1 3.5
Total 46
N.B many respondents gave more than one reasons as a grouped above.
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                                          Figure D.3 
  
 
 
  
 
 
 
  
3. Do you use the method consistently or all the time?
Table D.3
Yes (n) No (n) Total Consistency %
Condom Only users 26 2 28 93
Injectables only users 13 1 14 93
Condom+ Injectable 2 0 2 100
OCP only 2 0 2 100
IUCD only 1 0 1 100
0
5
10
15
20
25
30
Condom 
Only users
Injectables 
only users
Condom+ 
Injectable
OCP only IUCD only
Yes (n)
No (n)
4 Reasons for not using method consisitently?
Reasons Value(n)
No reasons 3
Total 3
All not using their method consistently said they have no reasons.
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                                                         Figure D. 5-8  
  
 
  
 
 
 
  
Section D. 5-8
Yes(n) No(n) Total Yes (%) No(%) Total (%)
5. Have you disclosed your  status to your partner 42 8 50 84 16 100
6. Have you made your partner get tested for HIV 39 11 50 78 22 100
7. Can you insist on condom use by your partner 44 6 50 88 12 100
8. Do you have plans to have more children 23 27 50 46 54 100
8a. Age Range of those (23) who have plans for more children
Table D.8a
Age Value(n) %
16-20 5 22
21-25 6 26
26-30 6 26
31-35 2 9
35-40 4 17
Total 23 100
Stellenbosch University  http://scholar.sun.ac.za
                                                         Figure D.8a 
  
 
 
 
 
 
 
  
                                          
 
 
 
 
 
No 8b. Number of living children in those who have pregnancy plans
Table D.8b
Number of living children Value (n) %
None 4 17.4
One 15 65.2
Two 3 13
Three 1 4.4
Total 23 100
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                                                                  Figure D.8b  
  
 
  
                Figure D.8c 
   
 
No 8c. The use of Nevirapine-based HAART by those who have pregnancy plans
Table D.8c
Group Value  (n)%
Using Nevirapine-Based HAART 15 65.2
Not Using Nevirapine-Based HAART 5 21.8
Not on any HAART 3 13
Total 23 100
Stellenbosch University  http://scholar.sun.ac.za
   
 
                                                       Figure D.9 
  
 
 
 
 
 
  
                                            
 
 
 
9. Does the plans for more children affect  your choice of contraceptive method?
Table D.9
Yes No Total
Value(n) 10 13 23
% 43 57 100
10. Does the benefit of getting child support grants has anything to do with your future pregnancy desires?
Table D.10
Yes No Total
Value(n) 12 11 23
% 52 48 100
Stellenbosch University  http://scholar.sun.ac.za
                                                  Figure D.10 
  
 
 
 
11. If the government replaces child support grants with Basic income grant for all 
unemployed people, will that change your contraceptive method? 
 
                                              Figure D.11 
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